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Summary
The transport of sugars by Trypanosoma brucei was 
investigated by measurement of influx and efflux of 
6-deoxy-D-glucose, a non-metabolised D-glucose analogue. 
The necessary protocols required the organic synthesis 
of radio-labelled 6-deoxy-D-glucose for which suitable 
methods were developed.
Kinetic analysis of 6-deoxy-D-glucose transport 
indicated that the transport process is by facilitated 
diffusion and may be the rate-limiting step in the 
glycolytic pathway, the sole means of energy production 
in bloodstream form trypanosomes. More extensive kinetic 
analysis using zero-trans and equilibrium exchange 
procedures indicated that the hexose transporter is 
kinetically symmetrical.
The appropriate transport procedures were used to 
analyse the specificity requirements of the hexose 
binding site on the transport protein. The results 
indicated that the binding of hexose to the transporter 
differed significantly from other hexose transport 
systems including the rat adipocyte and the human 
erythrocyte. In particular, there appeared to be greater 
spatial freedom at the carbon-2 position compared with 
other mammalian hexose transporters. This could have 
important implications in the design of specific anti­
trypanosomal agents.
The transport of 1-deoxy-D-glucose, a partially 
metabolised D-glucose analogue, indicated that the
phosphorylation of hexose may be closely linked to the 
transport process although phosphorylation was not a 
requirement for transport to occur.
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11.1: The importance of trypanosomes
Trypanosomes are parasitic protozoa responsible for 
a variety of serious diseases in humans and their 
livestock throughout vast areas of the world. The African 
trypanosome possesses a number of unique features, the 
most important of which allows the organism to avoid the 
immune response of the host and defy any attempts to 
develop a vaccine. These unique features combined with 
the lack of effective disease treatment and control have 
stimulated considerable scientific interest into all 
aspects of the protozoan and the diseases it causes.
The salivarian trypanosome Trypanosoma brucei brucei , 
the causative agent of the bovine disease 'nagana', 
is one of the most widely studied of any parasitic 
protozoa during the last 20 years. Trypanosoma brucei 
brucei is both morphologically and biochemically 
indistinguishable from the trypanosomes T. b . 
rhodesiense and T. brucei gambiense which,in man 
cause acute and chronic sleeping sickness respectively.
A component of human serum thought to be high density 
lipoprotein (Rifkin, 1978) brings about the lysis of 
T. b. brucei but not T. b. rhodesiense or T. b. gambiense. 
Trypanosoma brucei brucei is, therefore, preferred for 
experimental research offering high yields of the 
bloodstream-form by infection of rodents with no risk 
of human infection.
The classification of the brucei subgroup of 
























Figure 1: The classification of Trypanosoma brucei
(after Cox, 1982; Molyneux and Ashford, 1983).
3is subdivided into salivarian (salivary) or stercorarian 
(faecal) trypanosomes according to the mode of 
transmission by the insect vector. The main disease 
caused by stercorarian type trypanosomes, Chagas' 
disease, is caused by Trypanosoma cruzi. The 
trypanosome is passed from the hind gut of the vector, 
usually in reduviid (triatomid) bug, to the human host 
via the faeces through abrasions on the skin or through 
the internal mucosa following ingestion. It is estimated 
that between 13 and 14 million people are actually 
infected in Central and South America. The disease is 
chronic in nature although some 10-20% of the patients 
may eventually die due to secondary infections and the 
eventual autoimmune phase of the disease (Boreham, 1979; 
Fairlamb, 1982). There is no satisfactory treatment 
for the disease although some drugs are used in spite of 
the complex administration of the treatment and high 
toxicity of the drugs (Gutteridge, 1985).
1.2: Principal diseases caused by the T. brucei subgroup
1.2.1: African sleeping sickness
The protozoa which cause African sleeping sickness 
are classified as salivarian as they develop in the 
proboscis or salivary glands of the insect vector, being 
transmitted by an innoculative method during feeding 
(Smyth, 1976).
The chronic form of the disease is caused by 
infection with T. b. gambiense primarily in riverine
4areas of West Africa, (Figure 2) this being the preferred 
habitat of the Glossina palpalis group of tsetse flies 
(Figure 3) which carry T. b. gambiense. The more acute 
form of the disease is caused by infection with T . b . 
rhodesiense occurring mainly in the savannah of Africa 
(Figure 2). Transmission is mainly by the species 
G. morsitans, (Figure 3), which prefer open scrubland 
and wooded areas as a habitat.
If left untreated, the disease is invariably fatal, 
the time of death generally being related to the form 
of the disease. The chronic form usually leads to 
death after between nine months and three years 
(Donaldson, 1979), whereas the acute form can prove fatal 
within several months (Meshnick, 1984). Some 45 million 
people live in endemic areas of sleeping sickness of which 
about 10,000 new cases are reported annually (Goodwin, 
1985). However, only five million of these people are 
under regular surveillance and the actual incidence of 
sleeping sickness is probably much higher. In endimic 
areas of chronic sleeping sickness, epidemics regularly 
break out and the death toll can reach hundreds of 
thousands annually. These epidemics often occur during 
periods of economic or political difficulties when normal 
control measures often break down, such as occurred 
recently in Uganda (Gashumba, 1981).
The pathology of the two forms of sleeping sickness 
is very similar and it is often difficult to distinguish 
the form of the disease in areas where both can occur.
In general, pathological changes occur at the site of
5Figure 2: The distribution and occurence of sleeping
sickness in Africa. Solid dots indicate areas 
of T. b. rhodesiense endemicity. The open 
areas are T. b. gambiense foci which have 
a higher level of endemicity and from which 
epidemics arise (Molyneux and Ashford, 1983).
6Figure 3: Distribution of the tsetse fly belt in Africa.
Lined areas show the distribution of Glossina 
palpal is and dotted areas the distribution of 
Glossina morsitans, two of the major species 
of tsetse fly involved in the transmission 
of sleeping sickness (Molyneux and Ashford, 
1983).
7infection, in the bloodstream, in the extravascular 
spaces of the lymphatic and connective tissues and in 
certain visceral organs including the heart. In the 
later stages, the central nervous system (CNS), 
particularly the brain and spinal cord, become affected. 
In the acute form, death often occurs before advanced 
CNS involvement. The lymphatic glands are not normally 
affected and lesions of the heart are more frequent and 
severe (Donaldson, 1979). The actual means by which 
trypanosomiasis causes death is still uncertain 
(Markell and Voge, 1981), but it is known that the 
parasites have an immunosuppressive action often leading 
to secondary infections such as pneumonia, a frequent 
cause of death (Molyneux and Ashford, 1983).
The pathology of the disease manifests itself in 
man initially as an irregular intermittent fever. The 
patient complains of headaches, pains in the joints, 
loss of weight and pruritus. Oedema of the face and 
anaemia may also be present. In the early stages of 
CNS involvement insomnia may occur but as the disease 
advances, epilepsy, manical behaviour, somnolence and 
coma are typical (Molyneux and Ashford, 1983).
1.2.2: Nagana
Nagana, the disease caused by T. b. brucei used 
in this study is an extremely important disease in its 
own right affecting all the domestic animals raised 
by man. Up to 10 million square kilometres of Africa
8are infected with tsetse fly. This land is capable 
of supporting 140 million head of cattle while only 
20 million are actually grazed there (Molyneux and 
Ashford, 1983) and of these over three million die each 
year (Fairlamb, 1982). Extra cattle production would 
reduce dependence of some countries on imported meat, 
increase the nitrogenous content of the soil, make 
available more draught animals and raise the nutritional 
level of the population. The major diseases caused b y 1 
trypanosomes are summarised in Table 1. It is clear 
that the impact of the diseases is very large in world 
terms and it can be understood why the World Health 
Organisation has targeted trypanosomiasis as one of 
the six most important tropical diseases for scientific 
study (Trigg, 1979).
1.3: The variable surface antigen (VSA)
The diagnosis of human trypanosomiasis is often 
made difficult by a characteristic fluctuating 
parasitaemia with trypanosomes often undetectable in 
the bloodstream (Figure 4). This cyclic parasitaemia 
is due to the ability of the trypanosomes of the brucei 
subgroup to undergo antigenic variation. The bloodstream 
forms of T. brucei are completely enveloped in a 
monomolecular glycoprotein coat 12-15nm thick (Vickerman, 
1969), produced while the parasite occupies the salivary 
gland of the insect vector (Vickerman et al., 1980). The 
majority of the trypanosomes possess a single variant of
SPECIES VECTOR RESEVOIR HOST(S ) LOCATION DISEASE
T. Cruzi Triatomid 
bug
Armadillo Man S. and Central 
America
Chagas Disease













T. B. vivax Biting 
f 1 ies
Wild Game Cattle African tsetse 
fly belt
Nagana























S. America Mai de Caderas
Table 1: Table of the main disease carrying trypanosomes (Hoare, 1964; Markell and Voge, 1981).
2 4 6 8 10
Weeks
Figure 4 The fluctuating parasitaemia in the blood of 
a patient with African sleeping sickness 
(Wakelin, 1984).
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the surface antigen, the homotype, but a small minority 
possess heterotypical surface antigens. After infection, 
the hosts immune system quickly responds by raising 
antibodies to the homotype and the trypanosomes are 
destroyed by agglutination and complement-mediated lysis 
(Cox, 1982; Polter, 1985; Vickerman, 1985). The 
heterotypical VSA's are not destroyed and the most 
common heterotype becomes the new homotype (Figure 5).
It has been estimated that a single trypanosome 
possesses up to 1000 genes encoding for the VSA 
representing between 5 and 107o of the total genetic 
capacity of the organism (Donelson and Turner, 1985). 
Recently the genetics and structure of the VSA have 
been extensively studied in the hope of eventually 
developing a vaccine against sleeping sickness. The VSA 
is a glycoprotein with a molecular weight of 
approximately 65,000 (Cross and Johnson, 1976) consisting 
of a single polypeptide chain of approximately 600 amino 
acid residues (Mansfield, 1981). The outer N-terminal 
domain is highly variable in amino acid sequence 
(Whitfield, 1979). There is thought to be a more 
conserved area of amino acid sequence in regions 
concerned with attachment and three dimensional 
conformation (Cross and Johnson, 1976). The attachment 
of the molecule to the membrane is via covalent linkage 
of the carboxy-terminal of the polypeptide to glycosyl- 
sn-1,2-dimistryl-phosphatidylinositol in the trypanosomal 
membrane, and the release of the coat is catalysed by an














Antibody . Antibody 
Antigen . l  Antigen t \
Antibody > Antibody « Antibody « 
Antigen Antigen nAntigen
death of host or 
\  elicnination 
\  of parasites
time post-mfection
Figure 5: The role of antigenic variation in relapsing
infection. The rising parasitaemia consists 
primarily of long slender forms, and the 
falling parasitaemia, of short stumpy forms 
(Chappell, 1980).
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date there has been little success in the attempts to 
develop a vaccine. Currently the only possibility for 
vaccination against African trypanosomiasis seems to 
be against the limited number of VSA's which are 
expressed at the beginning of an infection (Donelson 
and Turner, 1985), although it is suggested that should 
these antigens be suppressed, another set would replace 
them (Kolata, 1984).
1.4: Control of African trypanosomiasis
The control of African trypanosomiasis centres on 
the avoidance of contact with the tsetse fly. This can 
be achieved by either moving human populations to tsetse 
fly-free areas or by reducing the man-fly contact by 
control of the size and distribution of the tsetse fly 
population. The former method is expensive, disruptive 
and not usually very effective as any success is quickly 
reversed by the breakdown of surveillance and diagnostic 
facilities which often occur in the African countries 
most at risk (Goodwin, 1985). The latter method depends 
on a variety of techniques including alteration of the 
habitat, pesticide application, genetic and biological 
control and physiological interference. Alteration of 
the habitat by clearing of the bush or the shooting of 
game animals is unacceptable on the grounds of conservation 
and is no longer in common use (Ukoli, 1984). Genetic 
control by the release of large numbers of sterilized male 
flies (Jordan, 1985) is expensive and has not been 
successful in eradicating the screw worm (Cochliomylia
14
hominivorax) in Northern Mexico where the influx of new 
flies from Southern Mexico has made complete control 
impossible. Similar difficulties are easy to envisage 
in Africa (Molyneux, 1982). Biological control by means 
of vector parasites or predators (Jordan, 1985) and 
physiological interference by means of insect growth 
regulators which inhibit chitin synthesis (Molyneux,
1982) are both subjects of continuing research. The 
use of insecticides by air or ground spraying is still 
widely practised in some areas of Africa but its limited 
effectiveness against sleeping sickness and the 
ecological and environmental impact restrict its 
suitability for more widespread use. The use of traps 
which attract tsetse flies both on a visual and with 
much more success, on an olfactory basis have been the 
subject of much interest recently. Synthetic organic 
compounds originally identified in ox breath have 
been successful in attracting tsetse flies to traps 
impregnated with insecticide. It is thought that 
suitable traps can reduce Glossina populations by over 
99% in riverine areas (Laveissiere and Couret, 1980). 
However, sufficient numbers of traps together with the 
materials and manpower to maintain them effectively 
would still represent considerable expense to the African 
countries concerned.
The incidence of nagana could be reduced by the 
exploitation of trypanotolerence shown by some breeds 
of cattle. These cattle, primarily humpless taurine 
breeds, are smaller and less prolific milk producers
15
than the more commonly kept zebu. It remains for long 
term breeding programmes to combine the most desirable 
characteristics of various breeds (Molyneux and Ashford,
1983) .
1.5: Anti-trypanosomal drugs
There are three main drugs currently in use for the 
treatment of African sleeping sickness. These drugs, all 
introduced before 1955 (Howells, 1985), are pentamidine 
for chemoprophylaxis, suramin for treatment of the early 
stages of the disease and melarsoprol for the later 
stages where CNS involvement occurs (Figure 6).
Pentamidine, a positively-charged aromatic diamidine, 
is the preferred agent for the prophylaxis of sleeping 
sickness and can also be used therapeutically against the 
early stages of the chronic and to a lesser extent the 
acute form of the disease. It cannot cross the blood- 
brain barrier and is, therefore, ineffective against the 
later stages when there is CNS involvement.
The selectivity of the drug for the parasite is due 
to the presence of a high-affinity energy-requiring 
transport system (Damper and Patton, 1976) which 
accumulates the drug in the parasite. The drug appears 
to exert its effect on the synthesis of deoxyribonucleic 
acid (DNA) with the synthesis of the uniquely trypanosomal 
kihetoplast DNA appearing to be particularly sensitive to 
disruption (Gutteridge, 1985). Side effects of 
pentamidine treatment are nephrotoxicity (Meshnik, 1985). 















2 ';c— ^-oich2i5o 
h n - \
, NH
NH-
Figure 6: The structures of the antitrypanosomal drugs
most commonly used in the treatment of African 
sleeping sickness. A = suramin, B = melarsoprol, 
C = pentamidine. (Gutteridge, 1985).
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apparent (Ree, 1985).
The sulphated-napthylamine suramin is also unable 
to penetrate the blood-brain barrier (Meshnik, 1984). The 
drug is administered to the patient intravenously and 
slowly taken up by endocytosis (Gutteridge, 1985). The 
drug works by inhibiting the enzymes involved in the 
reoxidation of NADH by the so-called oc-glycerophosphate 
shuttle (Figure 9) thus reducing the rate of glycolysis 
and respiration (Fairlamb and Bowman, 1980b). One of 
these enzymes, oc-glycerophosphate oxidase is found only 
in the trypanosome. The other, NAD+-linked 
oc-glycerophosphate dehydrogenase is found in both 
trypanosome and mammalian cells (Gutteridge, 1985). The 
selectivity of suramin is, therefore, not reliable and 
produces a range of serious side-effects varying from 
immediate nausea and collapse to blindness and renal 
failure, often fatal. The third drug melarsoprol, an 
aromatic arsenical can rapidly cure all stages of both 
chronic and acute African sleeping sickness. In cell- 
free homogenates, melarsoprol has been shown to inhibit 
several enzymes of carbohydrate metabolism including 
pyruvate kinase (Flynn and Bowman, 1974), glycerol kinase 
(Hammond and Bowman, 1980b) and oc-glycerophosphate 
oxidase (Fairlamb and Bowman, 1977). Trivalent 
arsenicals have a high affinity for sulphydryl groups 
which are present in the active sites of many enzymes, 
particularly kinases. Flynn and Bowman (1974) have shown 
that pyruvate kinase is the enzyme most affected in vivo 
as it is located in the cytoplasm of the cell. The
18
other enzymes mentioned are all present in a microsome- 
like organelle, the glycosome (Fairlamb, 1 9 8 2 ) .  The 
slight degree of preferential binding to trypanosomal 
pyruvate kinase over host pyruvate kinase gives some 
small degree of selectivity for melarsoprol (Gutteridge, 
1 9 85 ) .  There are however, serious side effects. Up to 
187o of patients suffer reactive encephalopathy which 
occasionally proves fatal and more commonly fever and 
pain in the chest and abdomen. Melarsoprol is usually 
only administered under close hospital supervision 
(Molyneux and Ashford, 1 9 8 3 ) .
It is clear from the description of the most widely 
used drugs that further research into anti-trypanosomal 
drugs is necessary. Current activity has moved away 
from the random screening of potential drugs to directing 
agents against unique aspects of trypanosomal metabolism 
and morphology. In this respect the current research into 
the biochemistry and molecular biology of trypanosomes 
provides valuable information which could lead to the 
development of an important new drug or vaccine.
1.6: The morphology and life cycle of T. brucei
There are several unique features of the morphology 
of the trypanosome which have been the subject of much 
recent research. The ultrastructure of a typical 
bloodstream form of trypanosome is shown in Figure 7.
One feature, the protein coat which can be shed to vary 
the surface antigen, has been described in Section 1.3.
19
l
Figure 7: The ultrastructure of a bloodstream form of
trypanosome. Long slender forms are 
approximately 30pm in length. Short stumpy 
forms are between 14 and 20pm in length.
A - fold of pellicle. B - attached flagellum. 
C - microtubules of pellicle (anterior end 
only). D - mitochondrion. E - endoplasmic 
reticulum. F - kinetoplast. G - basal body 
of flagellum. H - golgi apparatus. I - 
nucleus.
20
Beneath the plasma membrane a regular array of pellicular 
microtubules forms a cytoskeleton in both the vertebrate 
and invertebrate forms of the parasite (Molyneux and 
Ashford, 1983).
The kinetoplast located at the basal end of the 
mitochondrion is a complex network of mitochondrial 
DNA representing 307o of the total cellular DNA (Opperdoes, 
1985). One component of the kDNA network, the maxicircle, 
has features similar to mitochondrial DNA. The major 
transcripts are ribosomal and messenger RNA molecules 
(Fairlamb, 1982) and there is also evidence that the 
genes for cytochrome oxidase subunits I, II, and III and 
apocytochrome b are present within the maxicircles. 
The second component of the kinetoplast, the minicircles, 
of which there are approximately 6000, has a 
heterogeneous nucleotide sequence but as yet no known 
function (Opperdoes, 1985).
The trypanosome also contains a microsome-like 
organelle, termed the glycosome by Opperdoes and Borst 
(1977), containing the major enzymes of the glycolytic 
pathway, adenylate kinase and enzymes of the pyrimidine 
biosynthetic pathway (Opperdoes and Cottem, 1982). A 
single trypanosome contains an average of 230 glycosomes 
representing approximately 4.3% of the total cell volume. 
Each glycosome is spherical or eliptical and surrounded 
by a single membrane (Opperdoes et al., 1984).
The single mitochondrion present in trypanosomes 
undergoes striking changes during the various stages of
21
the lifecycle. In the insect stages, the mitochondrion 
is fully developed with numerous plate-like cristae, 
while the mammalian forms have a simple unbranched 
mitochondrion with few tubular cristae (Fairlamb, 1982). 
It is the development of the mitochondrion combined 
with the change in shape of the organism, the position 
of the flagellum (Hoare and Wallace, 1966) and the 
position of the kinetoplast relative to the nucleus 
(Vickerman, 1985) which describe the morphological 
stages of the life cycle (Figure 8 ).
The form injected by the infected tsetse fly into 
the host is the metacyclic form which rapidly transforms 
into the trypomastigote form which multiplies to form 
a characteristic chancre. The trypomastigotes migrate to 
the lymph nodes and then to the bloodstream. In a 
typical chronic relapsing infection, bloodstream forms 
display a heterogeneity of morphology known as 
pleomorphism (Markell and Voge, 1981). The long slender 
form is more numerous in the rising parasitaemia while 
the short stumpy form is usually seen in the remission 
stage. This is thought to be a preadaption for the 
insect stage of the life-cycle (Molyneux and Ashford, 
1985). After the tsetse fly has fed on the infected host 
the short stumpy forms ingested transform in the insect 
midgut to procyclic forms which multiply, then migrate 
to the salivary glands. In the salivary glands the 
procyclic form transforms first into the epimastigote 
then once again into the infective metacyclic form
22
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Figure 8: The developmental cycle of Trypanosoma brucei
in the mammalian host and the tsetse vector 
showing the relative sizes of the various 
stages. The forms marked with an asterisk 
are those in which division occurs. The forms 
marked with thick outer membranes are those 
with a protein coat (Vickermann, 1985).
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(Vickerman, 1985). Multiplication is believed to be by 
binary fission (Cox, 1982), however, the possibility of 
a sexual cycle in members of the brucei subgroup has 
been suggested by recent workers (Jenni et al., 1986: 
Vickerman, 1986).
The changes in morphology during the 1 ife-cycle 
are associated with the ability to adapt the respiratory 
pathway to the prevailing conditions. The principle 
energy source in the insect stage is proline, the amino 
acid most abundant in the haemocoel of the tsetse fly 
(Srivastava and Bowman, 1971) and the transformation 
from mammalian to insect form is accompanied by a marked 
increase in proline oxidase activity (Brown et al., 
1973). Proline is present at concentrations up to 
150mM, being the source of energy for insect flight 
(Bursell, 1966).
The transition from mammalian to procyclic insect 
form via the short stumpy form is accompanied by 
synthesis of certain enzymes of the tricarboxylic acid 
(TCA) cycle, cC-oxglutarate oxidase (Flynn and Bowman,
1973) for example. However, low levels of citrate 
synthase and succinate dehydrogenase seen in short . 
stumpy forms have led to the conclusion that the TCA 
cycle is not fully functional in vivo (Flynn and 
Bowman, 1973). The major end products of aerobic 
respiration in procyclic forms of T. brucei are 
succinate, malate, fumarate and aniline (Bowman and 
Flynn, 1976).
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The insect forms of the brucei subgroup have at 
least three terminal respiratory systems. Of these, one 
has cyanide-sensitive cytochrome a-a-3 as its terminal 
oxidase, one has salicylhydroxamic acid (SHAM)-sensitive 
-oc-glycerophosphate oxidase and the third, sensitive to 
neither SHAM or cyanide is as yet unknown but has been 
suggested as cytochrome-o (Njogu et al., 1980). The 
former two are the most important, contributing 60% and 
30% respectively to the total cellular respiration 
(Njogu et al., 1980).
1.7: Energy metabolism in bloodstream-forms of T. brucei
Energy production in the bloodstream-form of 
T. brucei is markedly different from those forms which 
inhabit the insect. The long-slender bloodstream form, 
as used throughout this work, possesses a simple 
mitochondrion, an incomplete TCA cycle and no functional 
respiratory chain (Fairlamb, 1982). Bloodstream 
trypomastigotes contain little if any storage 
carbohydrate (Opperdoes et al., 1976b) and are, therefore, 
reliant on glycolysis for the production of energy. The 
absence of external substrate results in rapid depletion 
of ATP levels (Opperdoes et al., 1976). Bloodstream 
trypanosomes respire actively on only four substrates: 
D-glucose, D-fructose, D-Mannose and glycerol (Ryley,
1956; 1962). In addition, short stumpy trypomastigotes 
will respire with cc-oxogluterate at about half the rate 
found with D-glucose (Flynn and Bowman, 1973). The
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human bloodstream contains D-glucose at a concentration 
of approximately 5mM (Whitfield, 1979), this constant 
supply eliminating the need for energy reserves in the 
parasite. Respiratory activity is correspondingly very 
high, oxygen consumption at 37°C being 120 - 180 nmol/ 
min/mg protein, compared to 1 - 10 nmol/min/mg protein 
for mammalian cells (Bowman and Flynn, 1976).
It may be to maintain this high rate of glycolysis 
that the major part of the glycolytic pathway is 
contained in the glycosome (Figure 9). As a consequence 
of the incomplete and non-functional TCA cycle and lack 
of lactate dehydrogenase in the bloodstream form (Bird 
et al. , 1971), glucose is metabolised almost exclusively 
to pyruvate under aerobic conditions, this being 
excreted into the bloodstream of the host (Ryley, 1956; 
Flynn and Bowman, 1973). The reduced NADH produced 
during the conversion of a triose phosphate to pyruvate 
is reoxidised by means of the oc-glycerophosphate oxidase 
(GPO) shuttle shown in Figure 9, located in the 
mitochondrion (Opperdoes et al., 1977). This terminal 
respiratory system is not sensitive to typical inhibitors 
of the mammalian respiratory chain, cyanide for example, 
and it is generally accepted that there are no functional 
cytochromes present in the bloodstream forms of organisms 
of the Trypanozoon subgenus (Ryley, 1956; Grant and 
Sargent, 1961; Ryley, 1962). It can be seen from Figure 9 
that the net production of ATP during aerobic respiration 
is 2 molecules, sufficient to maintain cellular function
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Figure 9: Pathways of glycolysis in bloodstream form
trypanosomes. The reactions enclosed in the 
broken box are assumed present under anaerobic 
conditions. The enzymes indicated are El - 
triosephosphate isomerase, E2 -fcglycero- 
phosphate dehydrogenase, E3 - glycerol kinase, 
E4 - ^-glycerophosphate oxidase. Other 
abbreviations: G6P - glucose 6 phosphate,
F-1,6DP - fructose 1,6 diphosphate, GAP - 
glyceraldehyde-3-phosphate, 1,3-diPG - 1,3 
diphosphoglycerate, 3-PG - 3 phosphoglycerate 
and PEP - phosphoenol pyruvate.
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(Brohn and Clarkson, 1980).
Under anaerobic conditions, the GPO shuttle is 
inoperative.D-glucose is metabolised to approximately 
equimolar concentrations of pyruvate and glycerol 
(Opperdoes et al. , 1976b). Thus the redox balance of 
the trypanosomes is maintained (Bowman and Flynn, 1976). 
Since bloodstream forms are able to survive anaerobiosis 
there must be a net synthesis of ATP. Several 
hypothetical schemes for the production of net ATP have 
been proposed (Clarkson and Brohn, 1976), but that which 
has most evidence to support was put forward by Opperdoes 
and Borst (1977) who suggest that glycerol and ATP are 
synthesised from oc-glycerophosphate (oc-GP) and ADP by 
glycerol kinase. During anaerobiosis the intracellular 
concentration of the glycolytic intermediate cx-GP rises 
by up to 30-fold (Hammond and Bowman, 1980a), with 
possible intraglycosomal concentrations of 0 .1M being 
reached (Opperdoes and Borst, 1977). Although the 
reaction described is thermodynamically unfavourable 
(Mackenzie et al., 1983) the reaction may proceed as a 
result of the high local concentration of oc-GP. The 
overall thermodynamics for the conversion of D-glucose to 
pyruvate and glycerol are however favourable and the 
necessity for an accumulation of oc-GP has recently been 
questioned (Hammond et al., 1985).
Recent work on the aerobic/anaerobic transition in 
T. brucei has shown that at physiological oxygen 
concentrations, the anaerobic pathway is almost inoperative 
(Eisenthal and Panes, 1985) so the function of anaerobic
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metabolism in bloodstream trypanosomes is largely unknown.
1.8: Substrate transport in trypanosomes
The bloodstream form of T. brucei is distinguished 
by having a very high metabolic rate (Bowman and Flynn, 
1976) coupled to the generation of metabolic energy solely 
by glycolysis. There has been considerable scientific 
interest in the glycolytic pathway as a potential site 
for action of anti-trypanosomal agents but relatively 
little attention has been paid to the transport of 
metabolic substrates. Work carried out on T. Lewisi 
(Sanchez and Read, 1969) measured uptake of radio-labelled 
substrates into trypansomes incubated at 37°C. This 
involved the addition of radio-label to preincubated cells 
followed by the addition of 4 volumes of cold buffer to 
stop uptake after 10 minutes. The cells were then 
processed over a 30 minute period. The results indicated 
that D-glucose uptake was saturable (Km = 1.25mM) and 
on the evidence of inhibitor studies, it was suggested 
that two sites of carbohydrate transport existed. The 
first was preferentially used by D-glucose, and the 
second site by D-glucosamine, D-fructose, D-galactose 
and 3-0-methyl-D-glucose. Similar results were shown 
in T. b. gambiense (Southworth and Read, 1969; 1970) 
using similar assay procedures to Sanchez and Read, (1969). 
Inhibition studies again indicated two uptake sites, one 
used by D-glucose, D-mannose, glycerol and 2-deoxy-D- 
glucose, the other by D-fructose and D-glucosamine.
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D-Galactose and 3-0-methyl-D-glucose did not inhibit 
uptake of glucose. Results from specificity studies 
using over 40 inhibitors in T. equiperdum (Ruff and Read,
1974) suggests the uptake system to be even more complex. 
Three sites of substrate uptake were proposed: a 'sugar'
site through which D-glucose, D-fructose and D-mannose 
are transported, a 'glycerol' site through which the 
substrates described above may be transported and a 
'glycerol' site for uptake of glycerol alone.
Gruenberg et al. , (1978) conducted a more detailed study 
of D-glucose transport in T. brucei. Their findings 
indicated that glucose is transported by an energy- 
independent carrier-mediated process and the permeation 
process is the rate-limiting step for the metabolism of D- 
glucose. Also, glycerol inhibition of hexose uptake 
was at the metabolic level rather than the carrier level. 
Whilst searching for a non-metabolised D-glucose analogue 
they found that 6-deoxy-D-glucose did not inhibit 
D-glucose uptake and 3-0-methyl-D-glucose did not follow 
Michaelis-Menten kinetics even at low concentrations.
All the work on substrate transport described 
followed the uptake of fully metabolised substrates or 
partially metabolised sugar analogues. Also, all 
measurements were under steady-state conditions rather 
than using initial rates. Under such conditions and 
with the extremely high metabolic rate of trypanosomes 
it is clear that interpretation of results solely in 
terms of the transport process is very difficult. This
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study was therefore initiated to attempt to investigate 
the kinetics and specificity of the transport process 
by the use of suitable uptake procedures using non- 
metabolisable sugar analogues.
1.9: Types of transport systems
The processes by which small molecules or ions 
traverse the plasma membrane can be generally classified 
as follows (Figure 10):
a) Simple diffusion: Molecules diffuse across the
membrane down their concentration gradients 
without the participation of specific carriers.
b) Facilitated diffusion: Molecules are conducted
across the membrane down their concentration 
gradient by stereospecific protein carriers. 
There is no energy-coupling so the substrate is 
not concentrated within the cell. As transport 
is catalysed by a finite number of specific 
carriers, facilitated diffusion shows saturation 
kinetics and can be inhibited by structural 
analogues of the transport substrate.
c) Active transport: Substrates are transported by
specific carriers but intracellular substrate 
concentrations may reach levels several hundred 
times that of the external medium. This 
accumulation against a concentration gradient 
requires the expenditure of energy, therefore 
active transport systems are also sensitive to
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Figure 10: Types of transport systems found in micro­
organisms (from Romano, 1986). Abbreviations: 
S, substrate; S-P, phosphorylated substrate; 
Pi, inorganic phosphate; X'-'P, high energy 
phosphate compound; PEP, phosphoenol pyruvate; 
I, II, III, group translocase enzymes I, II, 
III; HPr, heat stable phosphocarrier protein; 
BP, binding protein.
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metabolic inhibitors. There are two main 
classes of active transport mechanisms based 
on the means of coupling to metabolic energy:
i) Chemiosmotic coupling: In this system
metabolic energy is expended to remove ions from 
the cell so that an inwardly directing 
electrochemical gradient is created. The 
substrate is then transported along with the ion 
into the cell via a 'symport' and can accumulate 
as long as the electrochemical gradient is 
maintained. An example of such a system is the 
sodium-dependent D-glucose transport system in 
mammalian intestine and kidney tubules (Crane, 
1960) .
ii) Direct chemical energy coupling: This 
system transports substrates actively, energized 
directly by phosphate bond energy. In addition 
to a membrane-bound permease, a binding protein 
is also required for transport. This binding 
protein requires a distinct periplasmic space 
between the cytoplasmic membrane and the outer 
membrane and such systems are therefore only 
found in Gram-negative bacteria (Silhavy et al. , 
1978). The energetics of such systems are not 
well understood, but ATP is thought to be the 
probable energy source.
d) Group translocation: In this case substrates
are chemically altered during the transport
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process. The best known group translocation 
system is the phosphoenolpyruvate- sugar 
phosphotransferase system (PTS) that is widely 
distributed in bacteria (Kundig et al., 1964).
The PTS is a multicomponent system consisting 
of a number of proteins that participate in 
the transfer of a phosphate group from phosphoenol 
pyruvate to a number of sugars as they traverse 
the plasma membrane. As many as 12 different 
sugars can be transported by a given organism 
via the PTS. The sugar first appears in the 
cell as the phosphorylated derivative. The 
system plays a central role as a metabolic 
regulatory system. As phosphoenolpyruvate is 
a product of glycolysis, sugars can be 
accumulated without expense of ATP.
The evidence from previous work on sugar transport 
in T. brucei (Gruenberg et al., 1978) indicates that a 
facilitated diffusion system is operative for D-glucose 
uptake into trypanosomes.
1.10: Kinetic approaches to the study of sugar transport
The combination of a transported hexose with a 
membrane protein to form a transporter-substrate complex 
leads to saturation kinetics. This system differs from 
the familiar model of an enzymic reaction with one free 
enzyme form E (Scheme la) in that two separate binding
sites (E^ and E2 ) are available for the substrate (S), 
one on each face of the membrane. Scheme lb shows the
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most widely-used model for facilitated diffusion, the 
carrier model. The subscripts 1 and 2 refer to the two 
sides of the membrane. Transport is measured as the 
movement of substrate from side 1 to side 2 or side 2 
to side 1 .





Scheme la Scheme lb
Kinetic analysis of the carrier model for facilitated
diffusion will thus show half saturation constants (K ' s)m
and maximum velocities (V ' s) which have differentmax
interpretations depending on the direction of flux and 
the substrate concentrations on each side of the membrane. 
Eilam and Stein (1974) showed that for any of the 
following protocol descriptions the rate of flux (V) will 
be given by an equation of the Michaelis-Menten form:
V S
V = max (i)
K +S m
Kinetic constants for a facilitated diffusion system are 
analogous but not identical with those determined for an 
enzymic reaction.
A number of different experimental protocols are 
available to study the kinetics of facilitated diffusion.
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The main technique for measuring transport rates is to 
follow the flux of a non-metabolised radio-labelled 
substrate from one face of the membrane (the cis face) 
to the opposite face (the trans face). The cis to trans 
flux of the substrate can be measured either into 
(entry or influx) or out of (exit or efflux) the cell.
In all experiments unidirectional flux of the radio­
labelled substrate is followed. This can only be 
achieved by measuring initial rates either at very short 
uptake times (since backflux of radio-labelled substrate 
will occur at longer uptake times) or by the use of 
suitable integrated rate equations to compensate for the 
backflux which occurs at longer times.
1.10.1: Equilibrium exchange experiments
In these experiments the initial rates of unidirectional 
flux of radio-labelled substrate are measured when there 
is no concentration gradient across the membrane i.e., the 
substrate concentration in the cis solution is equal to 
that in the trans solution. Under these conditions there 
is no net flux of substrate and the rates of unidirectional 
efflux and influx are the same. The entry curve is 
nearly exponential and follows with close approximation 
the equation:
At = A «=(1 - e"kt> (2 )
Where A. and denote the amount of intracellular t °°
radioactivity at time t and infinite time respectively.
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The rate constant (k) is the transport velocity (V) 
divided by the substrate concentration (S). Thus 
equation 2 becomes:
In l/(l-f.)
K = V/S = ----- E —  (3)
where f. (fraction inside) = A,_/A .
1  t  eo
Therefore for equilibrium exchange experiments plots of
V/S vs t should be linear at any given substrate
concentration.
Once uptake has been shown to be exponential,
equation 3 can be used to calculate the initial uptake
rates. The value of V/S at different substrate
concentrations can be plotted using the transformation
of equation 1. For example the S/V vs. S plot (Hanes'
plot) transforms equation 1 into:
£ = Kf° + s (4 )
V V Vmax max
The equilibrium exchange V and K reflect the M ° max m
properties of both the internal and external sites of 
the transport system when substrate is being transported 
in both directions.
1.10.2: Zero-trans experiments
In these experiments the initial rate of flux of 
substrate from cis to trans is followed when there is 
initially no substrate in the trans solution. Thus for 
a zero-trans entry experiment, substrate and radio­
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labelled substrate are added to the external solution 
and the uptake is measured. The substrate enters the cell 
rapidly and therefore, over practical time courses, the 
substrate concentration will rise in the trans solution 
and backflux will occur. It is therefore, necessary to 
use an integrated rate equation to calculate the initial 
rate. Eilam and Stein (1974) described an integrated 
rate equation for the net entry experiment. The initial 
rate can be estimated by plotting:
where t is the uptake time*, C is the internal substrate 
concentration and S is the external substrate
concentration. This plot, therefore, shows the rate as a
function of the internal concentration as described by
the carrier model of Eilam and Stein. By extrapolating
the integrated rate plot to zero internal concentration
the initial rate of influx measured at different
substrate concentrations can then be replotted to
obtain the K and V for zero-trans entry. These m max J
kinetic parameters reflect the properties of the outside 
site.
During the inhibition studies in this work a 
simplification of the zero-trans experiment is used where 









where f is the fractional filling inside the cell, t is 
the time and S is the initial substrate concentration.
The rates calculated in this way approximate to the initial 
rate at low values of f. Therefore, uptake times were 
chosen to give fractional fillings of 40% or less.
In a zero-trans exit protocol, the cells are loaded 
with radio-labelled substrate until equilibrium is 
reached. The extracellular substrate is then rapidly 
diluted with a large quantity of buffer. This method 
does not give true zero-trans conditions but the small 
amount of substrate in the trans solution relative to 
the cis solution leads to minimal error. There is a 
rapid change in the substrate concentration at the cis 
face as efflux proceeds so an integrated rate equation 
treatment is required. The data from zero-trans efflux 
experiments can be conveniently analysed by an integrated 
Michaelis-Menten equation (Karlish et al., 1972) which 
can be rearranged (Baker and Naftalin, 1979) to give:
SW S V . ,t/ o _ max • t - 1 , -7 v
S -S. K S -S_ Ko t m o t m
where SQ is the starting substrate concentration inside 
the cell and St is the internal substrate concentration 
at time t. This equation is equivalent to a form of the 
Lineweaver-Burk transformation of the Michaelis-Menten 
equation:
!_ max 1 - 1 , £ \




'ln S -S.. S -S,.o t o t
a value of -1/Km can be obtained from the intercept on
the ordinate and 1/V is obtained from the interceptmax r
on the abscissa.
The kinetic parameters measured by this method 
reflect the properties of the inside transport site.
1.10.3: Infinite-cis experiments
In the infinite-cis experiments the net flux cis to 
trans is measured when the substrate concentration in the 
cis solution is saturating, that is, at least 10 times 
the zero-trans Km « The experiment is most easily 
performed by measuring the time course for net uptake of 
a single high concentration of substrate. As the uptake 
proceeds, the internal substrate concentration will 
increase from zero to equilibrium. Thus the substrate 
concentration in the trans solution is changing with 
time and this allows the determination of infinite cis 
entry parameters. Eilam and Stein (1974) showed that 
their integrated rate equation for net entry could be 
applied to the infinite cis protocol (Ginsburg and 
Stein 1975) so that a plot of:
-(ln(1-C/S + (C/S ))t o O / c \
c vs ------------C----------------- (5)
yields a straight line giving 1/V_a__ for infinite-cis
111 Cl u \ .
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entry as the intercept on the ordinate. The intercept 
on the abscissa will be:
-K /S 2 (1 + S /*■ ) m o  o
where * is the effective osmotic concentration of the
buffer and the K can thus be calculated (Holman, 1979).m
The V represents the maximum velocity for the outside max r J
site whilst the K reflects the affinity of the substrate
m J
for the inside site.
All the previously-described methods provide a 
kinetic analysis of a transporter and can determine the 
symmetry of the binding sites and contribute towards 
identification of a suitable kinetic model for substrate 
transport.
1.11: Aims of the project
1. To identify and if necessary, synthesise a 
radio-labelled non-metabolisable sugar analogue 
for the T. brucei hexose transport system.
2. To carry out a kinetic analysis of the D-glucose 
transporter, define the type of transport system 
and the kinetic parameters and establish
whether transport is the rate-limiting and 
possibly the regulatory step in the glycolytic 
pathway.
3. To investigate the specificity of the
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sugar-transporter protein and highlight any 
differences to mammalian and other transport 
systems with a view to exploiting suitable 
differences for the production of anti­
trypanosomal agents. These may be either 
strong selective inhibitors of transport or 
'poison' carriers which can release the 
'poison' once selectively transported into 
the trypanosome.
CHAPTER 2: MATERIALS AND METHODS
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2.1: Materials
All enzymes and cofactors were supplied by Sigma 
Chemical Company, Poole, Dorset. Reagents for organic 
reactions were supplied by Aldrich Chemical Company, 
Gilingham, Dorset. Ion exchange resins were supplied by 
BDH Ltd., Poole, Dorset and Whatmann Ltd., Maidstone, 
Kent. Silica gel-G60 and Silica gel-G60-F preformed 
thin-layer chromatography plates were from Merck, BDH 
Ltd., Poole, Dorset. Scintillation fluid was toluene: 
Triton X-100 (70:30) containing 2,5-diphenyloxazole 
(5g/l). All other reagents were of analytical grade or 
the highest grade available.
2.1.1: Radiochemicals
D- (U-^C)-glucose (275mCi/mmol) and 3-0-methyl-D-
(U-^C)-glucose (295mCi/mmol) were from Amersham
3
International, UK. ( H)-lithium aluminium hydride 
(473mCi/mmol) was from New England Nuclear Ltd.,
Boston, USA.
2.1.2: Buffers
Krebs-Ringer-Phosphate (KRP) buffer was prepared 








Krebs-Ringer-phosphate (G) buffer was Krebs-Ringer 
Phosphate buffer containing lOmM glucose.
2.1.3: Organisms used
Stocks of clones of long slender bloodstream forms 
of Trypanosoma brucei brucei strain EATRO 427-12/ICI- 
060 were kindly supplied by Dr Paul Voorheis and stored 
in sealed capillary tubes in liquid nitrogen. When 
required, a vial of these clones was thawed out and 10  ^
viable trypanosomes used to infect a single rat (See 
Section 2.2.1). At approximately 72 hours post-infection 
the rat was anaesthetised with diethyl ether and bled by 
aortic section into a syringe containing heparin and 
this blood was mixed with glycerol to a final 
concentration of 13% (w/v). Small volumes (approximately 
25pl) were then drawn into heparinised glass capillary 
tubes and these tubes, sealed at both ends, were stored 
in liquid nitrogen. These 'stabilates' (Lumsden and 
Hardy, 1965) were then used to provide viable 
trypanosomes for infection into rats (Lumsden, 1972) 
when cells were required for experimentation.
2.2: Methods
2.2.1: Infection of the host
Prior to infection, one 'stabilate' tube per rat
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(2-3 x 107 cells) was thawed, the sealed ends removed, 
and the contents rinsed out using a syringe containing 
0.75ml of KRP(G) buffer. The buffer was then injected 
intraperitoneally into Wistar or Sprague-Dawley rats 
(250-400g).
2.2.2: Tail count of the host
After approximately 60 hours, the degree of 
infection of the host was determined by removal of the 
tip of the tail and dilution of a sample of blood 
100-fold in KRP(G) buffer. The number of viable 
trypanosomes was determined using a Gallenkamp Neubauer 
haemocytometer-type counting chamber. The time taken 
to yield 10 cells per ml of blood was calculated using 
a doubling time of 7 hours (Brohn and Clarkson, 1980) 
and was usually found to be approximately 72 hours.
2.2.3: Isolation of trypanosomes from the host
The method described was adapted from that of 
Lanham and Godfrey (1970). After approximately 72 hours, 
the rats were anaesthetised using diethyl ether and bled 
into 20ml syringes containing 1ml of heparin solution 
(200 U/ml buffer). Bleeding was carried out at the 
aorta, situated in the dorsal abdominal cavity. The 
blood (10-14 ml/rat) was centrifuged for 10 minutes 
(800 x g, 4°C) in a bench centrifuge.
The trypanosomes formed a loosely packed layer 
above the red cells and below the plasma. The plasma
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was removed by aspiration and replaced with two thirds 
the plasma volume of KRP(G) buffer. The trypanosome 
layer was gently dispersed in the buffer by mild 
agitation with a pasteur pipette and removed. The wash 
stage was repeated several times to remove as much of 
the blood components as possible, The trypanosomes 
were then purified by passage through a column containing 
DEAE-cellulose (Whatman DE-52) pre-equilibrated with 
KRP(G) buffer at 4°C. This column retained the more 
negatively charged blood cells and platelets whilst 
allowing elution of a pure trypanosome suspension.
2.2.4: Preparation of a trypanosomal cell free extract
Cell free extracts were prepared as follows:
Freshly prepared trypanosomes were centrifuged for
10 minutes (800 x g, 4°C) in a bench centrifuge and
the pellet washed with 400mM triethanolamine buffer,
pH 7.4. The centrifugation was repeated and the cells
resuspended in the above buffer at a concentration of 
9
10 cells/ml of buffer. To 2ml of the cell suspension, 
0.5% v/v Triton X-100 was added.
The cells were then sonicated on ice for 90 
seconds in 15 second bursts followed by 30 seconds rest, 
using an Ultrasonics sonicator with a 4mm probe set at 
50 watts. The resulting clear suspension contained no 
intact trypanosomes when examined microscopically and 
was used in the hexokinase assay.
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2.2.5: Preparation of a crude glycosomal extract
A glycosomal extract was also used as a source of 
trypanosomal hexokinase activity. The method used was 
a simplification of that described by Panes (1987).
Cells were washed and resuspended in the following 
disruption buffer: 20mM triethanolamine, 0.5mM phenyl-
methyl sulphonyl fluoride (PMSF), ImM dithiothreitol 
(DTT), ImM ethylene diamine tetraacetic acid (EDTA),
250mM sucrose, 150mM potassium chloride (minimum volume 
= 5ml). The suspension was placed in a cooled mortar 
to which an approximately equal volume of silicon 
carbide (grade C6-F400) was added to form a thick paste. 
The paste was then vigorously ground until microscopic 
examination revealed greater than 95% cell disruption 
had occurred. The mixture was centrifuged for 5 
minutes (100 x g, 4°C). The supernatant was removed 
and the silicon carbide resuspended in disruption buffer. 
The centrifugation was repeated twice more and all the 
supernatants pooled. The supernatants were then 
centrifuged twice for 20 minutes (1000 x £, 4°C) in a 
bench centrifuge to remove large cell debris, followed 
by a further centrifugation for 20 minutes (14,500 x 
g, 4°C) in a Sorvall RC5-B centrifuge. The resulting 
glycosome-rich pellet was resuspended in incubation 
buffer (0.4M triethanolamine, pH 7.4, 0.5% Triton X 
-100) for use in the hexokinase assay.
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2.2.6: Extraction of radio-labelled sugars for thin layer
chromatographic (TLC) analysis
Cells containing the transported sugar analogues 
were 'stopped', centrifuged (See transport assay 
protocols) and the pellet resuspended in 50 to lOOpl of 
70% ethanol. The cells were centrifuged for 1 minute 
(20,000 x g, 0°C) and the supernatant carefully removed 
from the precipitated pellet. The extract was then 
applied to silica-gel TLC plates (20pl per track) and 
dried. The plates were developed in the appropriate 
solvent system, usually butanol:ethanol:water (52:33:15) 
or ethyl acetate:ethanol:water (90:10:6). When the 
solvent front had reached the top, the plate was removed, 
dried and divided into 4mm sections. Each section was 
carefully scraped into scintillation vials for counting 
of radioactivity. When non-labelled sugars were run as 
standards (5mg/ml) on TLC plates, the location of the 
bands was visualised by dipping the dried, developed 
plate into 5% sulphuric acid in methanol and burning 
off the solvent over a bunsen flame. The presence of 
sugar was indicated by black charring.
2.3: Transport and metabolism methods
2.3.1: 1-deoxy-D-glycose uptake protocol
Freshly prepared trypanosomes were dispensed into
Q
microfuge vials (10 cells/vial), each vial sufficient 
for one duplicate time point.
48
Immediately prior to the transport experiment the 
vial was centrifuged and the supernatant removed by 
aspiration using a microcapillary tube attached to a 
vacuum line. The cells were resuspended in 1ml of ice 
cold KRP buffer and recentrifuged. All centrifugations 
were carried out using an Ole Dich refrigerated micro­
centrifuge for 20 seconds (15,000 x g, 0°C) to ensure 
rapid processing of the cells. The washed trypanosome 
pellet was resuspended in 450pl of KRP buffer equilibrated 
to 37°C.
The trypanosomes (450pl) were placed in a small 
glass vessel enclosed in a water jacket maintained at 
37°C. This provided good thermal contact and allowed 
rapid equilibration after addition of any substances not 
maintained at 37°C. The cells were pre-incubated for 
30 seconds and incubation commenced by addition of 50pl 
of the appropriate concentration of radio-labelled
1-deoxy-D-glucose containing 0.5pCi of radio-label.
After the appropriate time interval duplicate 200pl 
samples were removed using a multichannel pipette and 
dispensed into vials containing 1ml of ice cold KRP 
buffer to stop the uptake.
The vials were centrifuged, the supernatants 
removed by aspiration and the pellets resuspended on a 
vortex mixer in 1ml of ice-cold KRP buffer. After a 
further centrifugation, the supernatants were removed 
taking great care to remove all small drops adhering to 
the sides of the vial. At the end of the experiment all
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pellets were resuspended in 0.5ml of distilled water and 
allowed to stand at room temperature for one hour to 
lyse the cells and release the radio-label. After lysis 
had occurred, 0.45ml samples were added to vials 
containing 5ml of scintillant for counting of radioactivity 
in a Packard Tricarb liquid scintillation counter.
Carry-over of non-transported radio-label was 
estimated by addition of radio-label to cells equilibrated 
at 2°C followed by immediate removal of samples to ice- 
cold stopping solution. Zero values were then subtracted 
from total CPM values measured.
Later kinetic and inhibitor studies on 1-deoxy-D- 
glucose used the improved protocol for zero-trans uptake 
of 6-deoxy-D-glucose (Section 2.3.3).
2.3.2: 1-deoxy-D-glucose efflux protocol
For study of 1-deoxy-D-glucose efflux, cells were 
prepared as described for uptake, up to the incubation 
with the radio-label. The cells were incubated for 
three minutes with the radio-label in a microfuge tube, 
then centrifuged and the pellet resuspended in 1ml of 
ice-cold KRP buffer. The cells were rapidly 
centrifuged and resuspended in 0.5ml of KRP buffer at 
37°C and placed in the glass incubation vessel. This 
process took 30 seconds to complete. At the appropriate 
time after resuspension, efflux was stopped by removal 
of 200pl samples to 1ml of ice-cold stopper and 
processed as described for the uptake experiment.
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Carry-over of extracellular radio-label was 
estimated by continuing efflux for 10 minutes before 
stopping the reaction. This zero-value was subtracted 
from all other values.
2.3.3: Zero-trans entry protocol
Freshly prepared trypanosomes in KRP(G) buffer 
were dispensed into the appropriate number of 3.5ml 
polypropylene tubes containing 1ml of cold KRP buffer 
(5 x 107 cells/tube, 1 tube = 1 uptake determination). 
An equivalent number of tubes were prepared containing 
2ml of ice-cold KRP buffer + 0.1% phloridzin for use as 
stopping solution. All the above tubes were maintained 
close to 0°C in an ice/water bath.
Solutions of radio-labelled 6-deoxy-D-glucose were 
prepared by the addition of 10pl of a 10-fold dilution 
of stock radio-label (specific activity = 8.53Ci/m mol) 
into the appropriate number of microfuge tubes (1.2pCi/ 
tube). For time-course experiments, a single 
concentration of unlabelled 6-deoxy-D-glucose was 
prepared (10 times the desired final concentration). A 
range of concentrations was used when carrying out 
kinetic constant estimations. To each microfuge tube, 
10pl of the appropriate concentration was added. All 
tubes containing labelled 6-deoxy-D-glucose were 
equilibrated to 20°C. These preparations, prior to the 
commencement of the assay, removed the need for precise 
pipetting during the course of the assay.
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The assay was commenced by centrifugation of one 
tube containing trypanosomes- (12,000 x £, 0°C, 20 
seconds) followed by resuspension in 1ml of cold KRP 
buffer. The centrifugation was repeated and the washed 
cells resuspended in 80pl of KRP buffer pre-equilibrated 
to 20°C. To begin the incubation the cells were 
pipetted into the appropriate tube containing the 
labelled sugar and incubated for the required period 
of time (final volume = lOOpl). Uptake was stopped by 
rapid addition of the cells to 2ml of ice-cold stopper 
solution. For incubation times of less than 10 seconds, 
a metronome set at two beats per second was used for 
timing purposes. The 'stopped' cells were centrifuged, 
the pellet resuspended in 1ml of stopping solution and 
the centrifugation repeated. The supernatant was then 
carefully removed by aspiration ensuring the removal 
of all adhering droplets. After all uptake estimations 
had been completed, the cell pellets were lysed by 
resuspension in 0.5ml of distilled water and left to 
stand at room temperature for 30 minutes The cell 
lysate was then dispensed into scintillation vials 
(0.45ml lysate: 5ml scintillant) for counting of
radioactivity.
Carry-over of extracellular radio-label was 
estimated by direct addition of cells resuspended in 
80pl of cold KRP buffer to stopper containing the 
radio-labelled 6-deoxy-D-glucose. The 'zero-time' counts 
were subtracted from all subsequent uptake values.
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Equilibrium values were obtained by incubation of 
cells for 60 to 120 seconds with labelled 6-deoxy-D- 
glucose. Using the equilibrium value, the fractional 
filling of the cells was calculated as follows:
CPM. - CPM
f =  £_______°
CPM oo - CPMq
Uptake was expressed in units of concentration 
sec ^(C). C was calculated as follows:
where S is the initial concentration outside the cells o
and t is the incubation time in seconds.
For single time point assays, an incubation time of 
three seconds was used to estimate the initial rate of 
uptake. This represented a fractional filling of 
approximately 40%.
2.3.4: Zero-trans exit protocol
Prior to commencement of the assay, the appropriate 
number of tubes containing 5 x trypanosomes and tubes 
containing 2.5ml of stopping solution were set up and 
maintained close to 0°C. Appropriate concentrations 
of labelled 6-deoxy-D-glucose were prepared by the 
addition of 3pl of 8.33 times the desired final 
concentration of unlabelled 6-deoxy-D-glucose to a 
microfuge tube containing 2pl of undiluted radio-label
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(2.4pCi/tube). The final concentrations used were 1,
2, 5 and lOmM. These tubes were equilibrated to 20°C.
The assay was commenced by washing the cells to 
remove extracellular D-glucose as described in the 
zero-trans entry protocol. The washed cells were 
resuspended in 20pl of KRP buffer maintained at 20°C.
The cells were then added to the appropriate radio-label 
(total volume = 25pl) and incubated for 5 minutes to 
ensure full equilibration. Efflux was commenced by rapid 
addition of the cells to 1.225ml of vigorously stirring 
KRP buffer contained in the same glass vessel used in 
the 1-deoxy-D-glucose uptake protocol (Section 2.3.1).
The mixture was incubated for the required time, then 
125pl was dispensed into 2.5ml of ice-cold stopping 
solution. Timing was aided by the use of a metronome 
set at two beats per second. The time intervals used 
ranged from 3 to 18 seconds thus building up a time- 
course of efflux at each concentration. The stopped 
cells were washed and processed for counting as described 
in the zero-trans entry protocol.
A zero-time point for efflux was obtained by rapid 
addition of the preincubated cells to 1.255ml of ice-cold 
stopping solution followed by immediate removal of 
125pl to 2.5ml of stopping solution. This reproduced 
the dilutions occuring for all the other time points. 
Zero-time points were determined for each concentration 
used but were found to be approximately equal indicating 
that full equilibration of the radio-label had taken place.
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A time point of 60-90 seconds after efflux had 
commenced was determined to account for trapped 
extracellular radio-label.
To obtain the kinetic parameters under these 
conditions, all the time points at each concentration 
were fitted and plotted using the integrated rate 
equation of Karlish et al., (1972) (see Results 4.3.4).
2.3.5: Equilibrium exchange entry protocol
The equilibrium exchange protocol was essentially 
the same as the zero-trans entry protocol except that 
cells were pre-equilibrated with the appropriate 
concentration of unlabelled substrate for three minutes 
prior to the addition of the same concentration of 
labelled substrate.
Cells were washed as described previously (Section
2.3.3) and resuspended in 7 5pl of KRP buffer at 20°C 
(5 x 107 cells). To commence preincubation lOpl of 8.5 
times the desired concentration of 6-deoxy-D-glucose was 
added and the cells mixed using a vortex mixer. To 
follow the uptake of radio-label, 15pl of the final 
desired concentraton of labelled 6-deoxy-D-glucose was 
rapidly added. The 15pl aliquot was made up of 5pl of 
three times the desired concentration of 6-deoxy-D- 
glucose plus lOpl of a 10-fold dilution of radio­
labelled 6-deoxy-D-glucose (1.2pCi/tube).
The cells were incubated for the desired time (3 
or 4 seconds) and stopped by rapid addition of the cells
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to 2ml of ice-cold stopping solution. The cells were 
then processed as previously described in Secion 2.3.3. 
An equilibrium value for uptake of radio-label was 
obtained by incubating the cells for 90 seconds prior 
to the addition to stopper.
A 'time-zero' value was obtained by addition of the 
pre-equilibrated cells directly to ice-cold stopper 
containing 15pl of radio-labelled 6-deoxy-D-glucose.
This value for trapped extracellular radioactivity was 
subtracted from all other values.
As there was no net flux of 6-deoxy-D-glucose into 
the cells under this protocol, the accumulation of 
radio-label closely approximated to a simple exponential 
curve. The time point used was thus not critical and 




where S is the substrate concentration, f is the o
fractional filling and t is the incubation time.
To determine the kinetic parameters under equilibrium 
exchange conditions, a concentration range of 0.1 to 
lOmM 6-deoxy-D-glucose was used.
2.3.6: Infinite-cis entry protocol
The infinite-cis entry protocol was effectively a
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time-course for uptake at a saturating external 
concentration of 6-deoxy-D-glucose. During this one 
time-course, the external substrate concentration 
remained saturating and the internal substrate 
concentration was continuously increasing with time. 
Correct analysis of the uptake profile can yield the 
kinetic parameters under infinite-cis entry conditions 
as described below.
The substrate concentration used was 40mM 6-deoxy- 
D-glucose, this being much higher than the zero-trans 
entry or exit Km values. The uptake protocol was 
exactly as described for the zero-trans entry protocol 
(Section 2.3.3).
The time course was replotted using the following 
form of the integrated rate equation:
-(ln(1-C/S ) - C / S ) 
t/C vs ---------- ^ --------—
The V and K were obtained as described in the max m
results section.
2.3.7: Substrate respiration using the oxygen electrode
The trypanosomal substrate respiration rate was 
determined by measuring the rate of oxygen consumption 
using a 'Clark' oxygen electrode (Beechey and Ribbons, 
1972) set up using a 12pm teflon membrane. Calibration 
of the electrode was carried out using KRP buffer through 
which air was bubbled for 1 hour.
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Zero percent oxygen was determined by the addition 
of a few grains of sodium dithionite (Na£ S2O4 ). The 
position of the chart recorder pen at 0% oxygen was 
equivalent to that obtained when short-circuiting the 
chart recorder. One hundred percent oxygen was assumed 
to be equivalent to a concentration of 240pM oxygen 
(Robinson and Cooper. 1970).
Water of an appropriate temperature (37°C or 20°C) 
was circulated through the jacket enclosing the electrode. 
Stock KRP buffer was also maintained at the appropriate 
temperature. The final volume of the solution contained 
in the electrode was 3ml and the mixture was stirred at 
a constant speed.
Trypanosomes were aliquoted into microfuge tubes
g
(3x10 cells per tube) and when required were washed 
by centrifugation (12,000 x £, 20 seconds, 2°C) and 
resuspension in KRP buffer to remove extracellular D- 
glucose. The cells were resuspended in 300pl of buffer 
and placed into the electrode containing 2 .6ml of
g
buffer (10 cells/ml). The appropriate concentration 
of substrate was then added to the chamber via the 
small hole in the lid using a lOOpl Hamilton syringe.
The rate of substrate consumption was determined 
from the gradient on the chart relating to oxygen 
consumption (1 molecule oxygen = 1 molecule substrate).
For inhibition experiments, the same procedure was 
carried out except lOOpl of the appropriate inhibitor 
concentration was added immediately prior to substrate 
addition. The volume of buffer was adjusted to maintian
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the final total volume to 3ml.
2.3.8: Hexokinase assay protocol
Hexokinase activity in T. brucei was determined by 
measuring the production of adenosine diphosphate (ADP) 
in a coupled system containing pyruvate kinase and 
lactate dehydrogenase at 25°C (Figure 11). The produc­
tion of NAD+ was measured using a Cecil CE-212 
ultraviolet spectrophotometer at a wavelength of 340nm.
The assay buffer (pH 7.4) contained 0.4M triethanolamine, 
2mM EDTA, 4mM M g C ^  4mM KC1, 0.5mM ATP, 0.5mM phosphoenol- 
pyruvate, 0.2 5mM NADH, 5U. of pyruvate kinase and 5U. of 
lactate dehydrogenase.
Trypanosomal hexokinase was assayed using either a 
crude glycosomal preparation or a sonicated cell lysate 
(Sections 2.2.5 and 2.2.6). The amount of hexokinase 
preparation added per assay was equivalent to that
Q
produced by 10 cells. A correction for NADH oxidase 
activity was determined by ommission of phosphoenol- 
pyruvate and the two coupling enzymes. The rate was 
found to be less than 0.5% of maximal hexokinase activity 
in the presence of D-glucose.
2.3.9: Intracellular D-glucose assay protocol
The method used was the glucose oxidase/peroxidase
0-dianisidine procedure.
Trypanosomes were incubated at room temperature for 
15 minutes in KRP(G) buffer. The cells were then washed
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1 -deoxy - D - glucose 




Figure 11: Reaction scheme for the assay of ADP
production coupled to the formation of 
NAD+ . HK = hexokinase as present in 
T. brucei cell preparation, PK = pyruvate 









twice by centrifugation and resuspension in ice-cold 
buffer. Cells were finally resuspended in 2ml of buffer
Q
at a concentration of 5 x 10 cells/ml. Triton X-100  
was added (0.17o) and the cells were sonicated on ice for 
9 0 -1 2 0  seconds in 15 second bursts followed by 30 
seconds rest using an Ultrasonics sonicator fitted with 
a 4mm probe set at 50 watts. The resulting lysed cell 
suspension was used to determine the intracellular 
D-glucose concentration.
The assay procedure utilized the following reactions:
i j-v -I . tt n glucose oxidase  ^ n1 . . A1. D-glucose + H2O --------— -------- ► Gluconic acid
+ O2 + 2H2O2
2 . ^2^2 + 0-dianisidine peroxidase—  ^ 0-dianisidine
reduced form oxidised form
(colourless) (brown)
+ h20
The assay constituents were in the form of a pre-weighed 
capsule containing 500 international units of glucose 
oxidase (Aspergillus niger), 100 purpurogallin units of 
horseradish peroxidase and buffer salts. The capsule 
was dissolved in 100ml of distilled water to which 1 .6ml 
of 0-dianisidine solution (2.5mg/ml) was added. The 
assay mixture consisted of 900pl. of enzyme/colour/buffer 
mixture and lOOpl of lysed trypanosomal extract. The 
cuvettes were mixed and left in the dark for 30 minutes 
to allow the colour to develop. For reference a standard 
D-glucose concentration curve was made up (0-2mM).
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The colour change was read using a Cecil CE-212 
spectrophotometer set at a wavelength of 450nm.
CHAPTER 3: CHEMICAL SYNTHESIS OF SUGAR ANALOGUES
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3.1: Synthesis of labelled 6-deoxy-D-glucose using
tritiated lithium aluminium hydride
3.1.1: Methyl-6-Chloro-6-deoxy-D-glucopyranoside
synthesis
The first stage of the synthesis of 6-deoxy-D 
glucose followed a modification of the method used by 
Evans and Parrish (1972) for the synthesis of 6-Chloro- 
6-deoxy-cc-D-glucoside:
Methane sulphonyl chloride (37.5ml, 56.5g, 5 moles) 
was added to a stirred solution of 19.4g of methyl-cc - 
D-glucopyranoside in 200ml of N, N-dimethylformamide 
cooled to 18°C in a water bath. The temperature was 
slowly increased to 70°C and maintained for 16 to 18 
hours. N-propanol (37.5ml) was then added to the hot 
solution which was maintained at 70°C for a further 
3 hours. The product was concentrated under reduced 
pressure at a temperature not exceeding 55°C using 
first a water aspirator, then an oil pump. The cooled 
solution was diluted with 500ml of water and left for 
1 hour at room temperature to hydrolyse formate esters 
formed in the reaction. The product was again concentrated 
under reduced pressure, the syrup dissolved in 10ml of 
ethyl acetate and then applied to a 6 x 50cm column of 
silica-gel. The product was eluted using ethyl acetate: 
ethanol:water, (90:10:6), the appropriate fractions being 
pooled and concentrated under reduced pressure. This
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yielded 12g (58.8%) of methyl-6-chloro-6-deoxy-D- 
glucopyranoside which was further purified by 
recrystallization from ethyl acetate: Final yield 10.9g
(53.4%), melting point: 111°C (Literature melting point
112°C-113°C) , = 0.50 on silica-gel pre-coated glass
plates developed in ethyl acetate:ethanol:water 
(90:10:6).
3.1.2: Protection of the free hydroxyl groups using
dihydropyran
The method used by Evans and Parrish (1972) involved 
the simple reduction of the chloro-sugar using lithium 
aluminium hydride (LiAlH^). This was not practical when 
using labelled LiAlH^ as tritium exchange with the free 
hydroxyl-groups on the chloro-compound would have wasted 
most of the label.
The first method of protection of the hydroxyl- 
groups used the compound dihydropyran, previously used 
for similar protection reactions (Wolfrom et al., 1968). 
The most suitable molar ratio of reactants was 5g of 
6-chloro-6-deoxy-cc-methyl-glucoside dissolved in 125ml 
of dry N, 'N-dimethyIformamide to which 40ml of 
dihydropyran was added along with catalytic amounts of 
toluene sulphonyl chloride. (Molar ratio of dihydropyran 
to each hydroxyl group 8 :1 ).
After one hour at room temperature approximately 
equal amounts of di- and tri-substituted sugar were 
present as judged by TLC and after a further 10 hours, a 
single band corresponding to the expected position of
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2 ,3 ,4- tetrahydropyranyl-6-chloro-6-deoxy-methyl-oc-D- 
glucopyranoside was obtained (R^ = 0.85 developed in 
ethyl acetate:ethanol:water, 90:10:6). Dichloromethane 
(100ml) was added to the reaction mixture and shaken with 
an equal volume of 1M potassium hydrogen carbonate. The 
aqueous layer was removed and the organic phase washed 
several more times, then concentrated under reduced 
pressure. No crystallization of the resulting syrup 
occured. This was thought to be due to the product 
being a mixture of stereoisomers. Subsequent TLC 
analysis supported this assumption by revealing several 
bands when developed in petroleum ether:ethyl acetate 
(4:1).
Approximately 8g (72.9%) of syrup was produced, 
half of which was purified on a silica-gel column eluted 
with the solvent mixture: petroleum ether:ethyl acetate 
(1:5). Of the three major isomers visualised, fractions 
containing only one product for two of the three bands 
were pooled and evaporated to dryness. These were then 
left to crystallize in the fridge for use in subsequent 
labelling of the protected sugar. The remaining syrup 
was used in a trial reduction using unlabelled LiAlH^.
3.1.3: Protection of the free hydroxyl-groups using
tertiary-butyl-dimethyl-silyl-chloride
Tertiary-butyl-dimethyl-silyl-chloride (t-BDSCl) 
was investigated as a potential protecting agent due to 
its symmetrical structure. Such a structure avoids the
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problem of producing stereoisomers and would allow the 
synthesis of 'clean' crystalline products. The 
conditions used in the reaction were as follows:
To a solution of lOOmg of 6-chloro-6-deoxy-a-methyl- 
D-glucoside in 2ml of N,N-dimethyl formamide, was added 
425mg of t-BDSCl. (2 equivalents/hydroxyl group) followed 
by 380mg of imidazole (imidazole:t-BDSCl; 2:1). All 
additions were carried out using thoroughly dried 
glassware under a stream of dry nitrogen gas.
The mixture was left at room temperature for 12 
hours. The progress of the reaction was monitored using 
TLC analysis developing the plates in ethyl acetate: 
petroleum ether (1:9). This revealed equal proportions 
of two new products: 0.45 and 0.49. Due to the close
proximity of the bands to each other, a chromatotron was 
used for the isolation of the products. This automated 
TLC procedure produced a successful separation of the 
two compounds which were then evaporated to dryness, 
crystallized and analysed using NMR spectrometry.
The ratio of the silyl-compound to the sugar revealed 
that both isolated compounds were sugar residues with two 
silyl-groups attached, each one presumably being a 
different isomer. This suggested that there may have 
been steric problems with the protection of all three 
hydroxyl-groups with the silyl compound. The reaction 
was allowed to proceed for seven days gradually increasing 
the temperature to 35°C. During this time, a small 
amount of product (R^ 0.75, ethyl acetate:petroleum ether,
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1:9) was produced. This was assumed to be the fully- 
protected sugar compound. However, due to the low yield 
and the length of time taken for the reaction to proceed, 
the method of protection of the free hydroxyl-groups 
using t-BDSCl was not further investigated.
3.1.4: Reduction of 2 ,3,-4-tetrahydropyranyl-6-chloro-
6-deoxy-methyl-oc-D-glucoside
The protected glucoside (3.95g) was dissolved in 
10ml of freshly distilled tetrahydrofuran (THF). This 
solution was then carefully added to a vigorously-stirred 
suspension of 0.6g LiAlH^ dispersed in 40ml of THF. The 
mixture was refluxed for 18 hours and, after cooling, a 
further 0.4g of LiAlH^ in 10ml of THF was added. After 
an additional 18 hours of refluxing any remaining LiAlH^ 
was neutralised by the very careful dropwise addition 
of 20ml of 157o sodium hydroxide solution and removal of 
the insolulable salts by filtration. The aqueous 
solution was washed four times using 50ml of 
dichloromethane to extract the protected sugar into the 
organic phase. Anhydrous sodium sulphate was added to 
dry the solvent. The solution was finally evaporated to 
dryness to yield 3. 2g (867.) of crude product. The yield 
assumes that no impurities were present.
3.1.5: Mild acid-hydrolysis of 2,3,4-tetrahydropyranyl-
6-deoxy-oc-methyl -D-glucoside
A solution of 10ml of 507o ethanol containing lg of
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the reduced sugar compound was made up, to which 6g of 
pre-washed Dowex-50 (H+ form) ion-exchange resin was 
added. The mixture was heated for 4 hours at 70°C then 
allowed to cool. The ion-exchange resin was removed 
by filtration and thoroughly washed with distilled water. 
The resulting aqueous solution was evaporated to dryness 
under reduced pressure. The syrup was then dissolved in 
solvent (ethyl acetate:ethanol:water, 90:10:6) and 
purified using a 10cm x 2.5cm silica-gel column eluting 
with the above solvent mixture. Thin layer chromatography 
revealed three products: = 0.42, 0.31 and 0.15
(solvent; ethyl acetate:ethanol:water).
The product: = 0.15 corresponded to standard
6-deoxy-D-glucose. The two remaining products were 
crystallized and analysed using nuclear magnetic resonance 
(NMR) spectrometry.
The major product (R^ = 0.31, 42. 770) was 6-deoxy-D-<x - 
methyl-glucoside and the minor product was unreacted 
6-chloro-6-deoxy-oC-methyl-D-glueoside.
3.1.6: Strong acid-hydrolysis of 6-deoxy- -methyl-D-
glucoside
A solution of 160mg of 6-deoxy-oc-methyl-D-glucoside 
dissolved in 10ml of 1M hydrochloric acid was refluxed 
for 4 hours. The solution was cooled and neutralised 
with pre-washed Amberlite IRA-93 (OH form) ion-exchange 
resin. The neutralised solution was evaporated to 
dryness under reduced pressure and analysed using TLC.
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The analysis revealed a single product (R^ = 0.14) 
corresponding to standard 6-deoxy-D-glucose (solvent 
mixture; ethyl acetate:ethanol:water, 90:10:6).
Further purification by paper chromatography and 
crystallization of the product was not attempted.
3.1.7: Synthesis of radio-labelled 6-deoxy-D-glucose
An attempt was made to radio-label the previously 
isolated isomer of 2,3,4-tetrahydropyranyl-6-chloro- 
6-deoxy-oc-methyl-D-glucoside by reduction using 
tritiated LiAlH^. Unlabelled LiAlH^ (1.6mg) was rapidly 
added to 2ml of freshly distilled THF. The suspension 
was then added to the ampoule containing the tritiated 
LiAlH^ (0.4mg, 5mCi, specific activity = 473.8 mCi/ 
mmole) immediately after opening. The suspension was 
immediately transferred to a reaction vessel containing 
lOmg of the sugar residue and refluxed for 48 hours.
All the previously described operations were carried 
out under a stream of dry nitrogen gas using thoroughly 
dried glassware.
After reflux for the required time, the mixture 
was cooled and a small sample neutralised by the addition 
of a few drops of distilled water. Subsequent TLC 
analysis revealed that no labelled product was detectable 
The reaction mixture was refluxed for a further 48 hours, 
cooled and unreacted LiAlH^ decomposed by the addition 
of distilled water. Chromatography again revealed that 
no radio-labelled product was present. (See discussion).
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A repeat of the reduction using tritiated-LiAlH^ 
was not able to be carried out due to the supply of 
LiAlH^ being permanently discontinued by the sole 
supplier.
3.2 Synthesis of 6-deoxy-D-glucose using the catalysed
halogen/tritium exchange method
The alternative method of synthesis of radio­
labelled 6-deoxy-D-glucose investigated was the catalysed 
halogen/tritium exchange service provided by Amersham 
International, Amersham, UK. The recommended substrate 
for the exchange procedure was 6-Iodo-D-deoxy-oc-methyl- 
D-glucoside.
Several procedures for the synthesis of the required 
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Several problems were encountered with methods A) and B) 
such that no product could be readily identified or 
purified (See Discussion). Method C) was however 
successful and is described in detail below.
3.2.1: Halide exchange of 6-chloro-6-deoxy-oc-methy 1-
D-glucoside
This method of producing the iodo-sugar utilised 
6-chloro-6-deoxy-oc-methyl-D-glucoside prepared previously 
(Section 3.1.1). An appropriate amount of 6-chloro-6- 
deoxy-oc-methyl-D-glucoside was thoroughly dried overnight
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in a dessicator and 500mg added to 25ml of dry acetone.
To this, 8g of sodium iodide was added and vigorously 
shaken until the acetone was saturated with the salt. The 
solution was then placed in an airtight glass tube and 
heated in an oven for 2 hours at 120°C. The solution was 
then cooled to room temperature. At this stage, a small 
amount of solid material was visible in the glass tube. 
This was assumed to be insoluble sodium chloride formed 
during the reaction.
The acetone was evaporated under reduced pressure 
leaving a blue/brown precipitate which was dissolved in 
10ml of distilled water. To this, approximately 15g of 
pre-washed Amberlite MB-1 ion-exchange resin was added.
The resin was then removed by filtration and thoroughly 
washed with distilled water. The aqueous solution was 
concentrated under reduced pressure and the resulting 
syrup dissolved in a small volume of ethyl acetate: 
ethanol:water, 90:10:6). This was then applied to a 
2.5 x 20cm column of silica-gel and eluted with the 
above solvent mixture under mild pressure.
The fractions containing the sugar compound were 
pooled and concentrated under reduced pressure to give 
a solid material which was further purified by 
recrystallization from ethyl acetate. Analysis by 
mass-spectrometry revealed the crystalline product as 
6-iodo-6-deoxy-oc-methyl-D-glucoside, yield = 25mg 
(3.5%), Rf = 0.41 (ethyl acetate:ethanol:water. 90:10:6)
(Chloro-sugar = 0.37).
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3,2.2: Catalytic halogen/tritium exchange
The product (22.5mg) was sent to Amersham for the 
catalytic halogen/tritium exchange procedure to be 
carried out. The reaction yielded 630mCi of 6-deoxy- 
oc-methyl-D-glucoside, specific activity = 8.53 Ci/mmol.
3.2.3: Acid hydrolysis of 6-deoxy-oc-methyl-D-glucoside
A lOmCi aliquot of the product was removed and 
evaporated to dryness under a stream of nitrogen gas.
The labelled compound was dissolved in 2ml of 1M 
hydrochloric acid. The solution was then refluxed 
for 4 hours, cooled and neutralised using Amberlite 
IRA-93 (0H~) ion-exchange resin after dilution with 
10ml of distilled water. The aqueous solution was 
then concentrated under reduced pressure. TLC 
analysis revealed a single radioactive product, =
0.17 (Figure 12). The plates were developed in ethyl 
acetate ‘.ethanol:water, (90:10:6).
The R^ value for the radio-labelled product was 
the same as standard 6-deoxy-D-glucose solution.
3.2.4: Purification by preparative paper chromatography
The radio-labelled 6-deoxy-D-glucose was purified 
using paper chromatography to remove any potential non­
radioactive contaminants. A 30cm piece of Whatmann-3MM 
filter paper was cut and folded, to which a 1cm wide box 
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Figure 12: TLC analysis of labelled 6-deoxy-oc-methy 1-
glucoside (±) and labelled 6-deoxy-D- 
glucose (•). Counts per minute are shown 
as per slice from the TLC plate vs. the 
distance of the slice from the origin.
Solvent system: ethyl acetate:ethanol:water,
(90:10:6).
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either edge. The aqueous solution containing the sugar 
(200yl) was carefully applied within the box and allowed 
to dry. The flask containing the radio-labelled sugar 
was rinsed with 200pl of distilled water which was then 
applied to the box and up to each edge of the paper.
The paper was developed overnight in butanol:ethanol:water, 
(52:33:15) and dried in a fume cupboard. The strips at 
each edge of the paper were removed and divided into 1cm 
sections. These were then placed in scintillation vials 
and the radioactivity counted to reveal the location 
of the radio-label on the paper. The appropriate area 
of paper was cut out and eluted with distilled water.
The eluant was aliquoted into microfuge vials and stored 
at -20°C. Final yeild, 6.37mCi (63.7%) of 6-deoxy-D- 
glucose in 3.73ml of distilled water (210pM).
3.3: Synthesis of radio-labelled 1-deoxy-D-glucose
The synthesis of 1-deoxy-D-glucose was adapted from
the method of Ness et al., (1950):
14lmCi of D-(U- C)-glucose in ethanol:water. 9:1 
was evaporated to dryness and stored overnight in a 
dessicator. The following day, 1ml of acetic anhydride 
and 1ml of pyridine were added to the D-glucose and 
the flask shaken for 24 hours at room temperature. The 
product was extracted into 50ml of chloroform and washed 
first with 50ml of lOOmM hydrochloric acid then 100ml 
of distilled water. The aqueous phases were washed with 
20ml of chloroform which was pooled with the chloroform
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extract. The reaction yielded 99% labelled D-glucose 
pentacetate which was dried over sodium sulphate overnight. 
The chloroform extract was evaporated to dryness under 
reduced pressure and 1ml of 45% hydrogen bromide in 
glacial acetic acid was added. The mixture was shaken 
for 2 hours at room temperature then extracted into 50ml 
of chloroform. The chloroform extract was washed twice 
with 100ml of distilled water followed by 100ml of ice- 
cold saturated sodium hydrogen carbonate solution. The 
yield was 64% l-bromo-2,3,4,6-tetra-acetyl-D-glucose•
The extract was dried overnight and evaporated under 
reduced pressure. The 1-bromo-tetra-acetyl-D-glucose 
was dissolved in 5ml of diethyl ether and added dropwise 
to lOOmg of LiAlH4 suspended in 2ml of diethyl ether.
The suspension was stirred for 30 minutes at room 
temperature in the dark followed by very careful 
dropwise addition of distilled water to decompose excess 
LiAlH^. The water phase was then separated from the 
diethyl ether phase and the diethyl ether washed with 
50ml of distilled water. Pre-washed Amberlite MB-1 ion- 
exchange resin was added to the aqueous solution to 
remove the salts that were produced. The ion-exchange 
resin was separated from the solution by filtration 
and washed with distilled water. The aqueous phase 
was evaporated to dryness under reduced pressure and 
resuspended in 150pl of distilled water. TLC analysis 
revealed a major product = 0.51 developed in butanol: 
ethanol:water, (52:33:15) corresponding to standard
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1-deoxy-D-glucose solution.
The radio-labelled product was purified using 
paper chromatography as previously described (Section
3.2.4). The elution profile is shown in Figure 13.
The final purification yielded 503pCi of 1-deoxy- 
D-glucose, specific activity 275mCi/mmol. Overall 
percentage yield = 50.3%.
3.4: Synthesis of 6-chloro-6-deoxy-D-glucose
The product 6-chloro-6-deoxy-oc-methyl-D-glucose 
previously synthesised (Section 3.1.1) was hydrolysed 
to produce 6-chloro-6-deoxy-D-glucose by the following 
procedure: 1 gram of 6-chloro-6-deoxy-ot-methyl-D-
glucoside dissolved in 10ml of 1M hydrochloric acid 
was refluxed for 6-8 hours. The solution was cooled 
and neutralised with Amberlite IRA-93 (OH ) ion-exchange 
resin. The resin was separated by filtration and washed 
with distilled water. The aqueous solution was 
concentrated under reduced pressure and purified on 
a 2.5 x 20cm silica-gel column. The 6-chloro-6-deoxy 
D-glucose was eluted with butanol:ethanol:water (52:33:15), 
the relevant fractions pooled and concentrated to dryness. 
Further purification by recrystallization from ethyl 
acetate yielded 0.27g of white feathery crystals of 
6-chloro-6-deoxy-D-glucose. Yield = 27%.
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Figure 13: Elution profile of the paper chromatogram
of the final product in the synthesis of
1-deoxy-D-glucose. The paper corresponding 
to the large peak was removed and the product 
eluted with water. This product was 1-deoxy- 




4.1: Substrates of T. brucei
4.1.1: Specificity of substrate metabolism
The oxidation of substrates by the bloodstream 
form of Trypanosoma brucei was investigated using a 
Clark type oxygen electrode to measure the rate of 
oxygen consumption as a function of substrate metabolism.
The results shown in Table 2 confirmed that the 
substrates metabolised by T. brucei were D-glucose, 
D-mannose, D-fructose and glycerol. The rate of 
oxygen consumption by trypanosomes incubated with a 
ImM concentration of each of these substrates was 
approximately the same. The background rate of oxygen 
consumption without substrates was similar to the rates 
obtained using D-galactose, oc-glycerol phosphate and 
inosine, these potential substrates therefore not being 
metabolised to any extent.
The results in Table 2 were confirmed by microscopic 
examination. Cell numbers and cell motility were 
examined over a 60 minute period and remained constant 
when metabolism of substrate was occurring. In cases 
where no metabolism was observed, the cells lost all 
motility after a 10 minute incubation period and 
substantial cell lysis had occurred after 60 minutes 
of incubation. With glycerol, some loss of cell motility 
was observed after 60 minutes incubation. This was 












<* -GLYCEROL PHOSPHATE 0.2
INOSINE 0.3
Table 2: Table of substrate oxidation rates of 37°C




The kinetic parameters of D-glucose metabolism
were calculated using the oxygen electrode. The values
obtained (Figure 14) were: K = 3.22 t 0.07mM andm
g
V = 62.7 t 7.5 nmoles/min/10 cells. The maximum max
velocity is within the range measured by Flynn and
Bowman (1973) at 37°C.
The kinetic parameters of D-glucose metabolism were
also calculated at 20°C to allow comparison with
transport assay rates measured at this temperature. The
kinetic parameters calculated were K = 0.387 t O.llmM r m
and V = 20.3 t 0.93 nmoles/min/10^ cells (Figure 15). max °
Both Km values were similar but increasing the temperature
significantly increases the V for glucose metabolism.° J max °
4.1.2: Inhibition of D-glucose oxidation
The inhibition of the metabolism of D-glucose was 
measured by addition of the appropriate amount of 
potential inhibitor to the electrode immediately prior 
to D-glucose addition. The rate of oxygen consumption 
was compared to that with no inhibitor present. The 
percentage inhibition by 3-0-methyl-D-glucose and 
6-deoxy-D-glucose is shown in Table 3 whilst Figure 16 
shows the percentage inhibition of D-glucose oxidation 








Figure 14: Hanes plot of D-glucose oxidation rate vs.
D-glucose concentration at 37°C by T. brucei.
K = 0.322 t 0.07mM, V = 62.7 + 7.5 nmol/ m g max







Figure 15: Hanes plot of D-glucose oxidation rate vs.
D-glucose concentration at 20°C by T. brucei.
K = 0.387 + O.llmM, V = 20.3 t 0.93 nmol/ ro g max








Figure 16: Inhibition of the rate of D-glucose
respiration in T. brucei by 40mM 1-deoxy-
D-glucose. Percentage inhibition given by
100 x (l-V./V ) where V. and V are the rates 
1 0  1 o
of oxygen utilisation in the presence and 












nmol/min/10 cells 31.8 1.9 6.6
7, Inhibition - 94.1% 79.3%
Table 3 : Inhibition of D-glucose metabolism by 6-deoxy-
D-glucose and 3-0-methyl-D-glucose at 37°C.
It was clear from the results that the 3 analogues 
examined all had an inhibitory effect on substrate 
metabolism, 6-deoxy-D-glucose being the most potent 
inhibitor. The analogue 1-deoxy-D-glucose appeared to 
be the least effective inhibitor with a 40mM substrate 
concentration causing only 437. inhibition at ImM 
substrate concentration compared with 797. inhibition by 
lOmM 3-0-methyl-D-glucose. The results were, however, 
from different experiments and direct comparisons may 
not be applicable as the inhibition by 1-deoxy-D-glucose 
was measured by addition of inhibitor to cells after a 
steady state of D“glucose respiration had been reached.
The degree of inhibition of D-glucose metabolism 
resulted in all the analogues being considered as 
potential non-metabolised D-glucose analogues. It was 
necessary to determine that inhibition did occur at the 
transport stage of D-glucose metabolism and not at a
85
later stage in the metabolic pathway.
4.2: 1-deoxy-D-glucose transport
Preliminary experiments using 3-0-methyl-D-glucose 
as a substrate in a transport assay indicated that the 
analogue was not a suitable substrate as the rate of 
transport was too slow. The experiments did, however, 
show that both 6-deoxy-D-glucose and 1-deoxy-D-glucose 
were effective inhibitors of 3-0-methyl-D-glucose uptake 
and the availability of radio-labelled 1-deoxy-D-glucose 
allowed the investigation of its uptake into Trypanosoma 
brucei.
Preliminary results indicated that uptake occurred 
at a significantly faster rate than with 3-0-methyl-D- 
glucose and that measurements of initial rates of uptake 
in cells starved of metabolisable substrate were feasable 
before cell death and lysis occurred.
4.2.1: Metabolism of 1-deoxy-D-glucose
It was important to establish whether 1-deoxy-D- 
glucose was metabolised after uptake had occurred and this 
was investigated by determining the specificity of the 
analogue for hexokinase from Trypanosoma brucei.
The assay used was a coupled enzymic assay measuring 
the production of ADP in the hexokinase-catalyzed 
reaction. Trypanosomal hexokinase was prepared either 
via a crude glycosomal preparation or a cell-free extract
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(See Methods).
The results (Table 4) indicated that with a fully 
functioning assay procedure with respect to 
phosphorylation of D-glucose, the rate of phosphorylation 
of 1-deoxy-D-glucose was less than 0.17, of the D-glucose 
phosphorylation rate. No inhibition of the rate of D- 
glucose phosphorylation by 1-deoxy-D-glucose was detected 
up to inhibitor to substrate ratios of 40:1. This was 
also true of 6 -deoxy-D-glucose which cannot be 
phosphorylated and did not inhibit the enzyme.
These results suggested that 1-deoxy-D-glucose may 
be a suitable non-metabolized analogue for D-glucose 
transport in T. brucei.
4.2.2: 1-deoxy-D-glucose kinetic experiments
Figure 26a shows a time-course of 1-deoxy-D-glucose 
uptake. The sugar appeared to reach equilibrium after 
approximately two minutes. Beyond this time, trapped 
label was rapidly lost from the cells, this being 
initially interpreted as onset of cell lysis after 
depletion of metabolic substrate.
The internal volume accessible to the analogue 
was calculated from the equilibrium value of the time- 
course and others like it. The value obtained was
g
5.9pl/10 cells, This value is higher than that 
calculated by Voorheis and Martin (1980) but less than 
the value calculated by Damper and Patten (1976).



























ImM D-glucose 0.94 ± 0.03*
250pM D-glucose 0.52 ± 0.03
250pM D-glucose 




+ lOmM 6 -deoxy- 
D-glucose
0.51 t 0.02
Table 4: The activity of hexokinase with 1-deoxy-D-
glucose, 6-deoxy-D-glucose and D-glucose. The 
activity was measured using a coupled enzyme 
assay measuring the formation of NAD+ . The 
hexokinase was present in a crude cell lysate or 
a glycosomal preparation prepared from T. brucei. 
* ± range, n = 2 .
88
anomalous results. The zero-trans entry kinetic
parameters were: K = 4.03 t 0.42mM and V = 0.052 t r m max
0.005mM sec  ^ (Game et al., 1986), the maximum velocity 
being particularly slow for such a rapidly metabolising 
organism.
Attempts to measure efflux indicated that the rate 
was much slower than that of uptake and inhibitor 
experiments produced peculiar biphasic inhibition 
profiles suggesting two sites of inhibition. It was 
clear that either the transport system for 1-deoxy-D- 
glucose was not a straightforward facilitated diffusion 
system, or the methodology used was inadequate for 
correct measurement of uptake.
To further investigate the transport process, a 
counter-flow experiment was carried out preincubating 
the cells with lOmM 1-deoxy-D-glucose for 10 minutes 
prior to addition of labelled analogue. The results 
shown in Figure 17 indicated that there was little 
difference in the uptake profile of the counter-flow time- 
course and the zero-trans time-course. This suggested 
that in the zero-trans experiment, the label was being 
accumulated above the value expected at equilibrium and 
the subsequent efflux of label was not due to cell lysis 
but to the loss of the agent or process causing the 
initial accumulation. This would mean that the time-course 
of 1-deoxy-D-glucose uptake was wrongly interpreted as 
uptake until equilibrium had been reached and the true 










Figure 17: Uptake of 3pM 1-deoxy-D-glucose after 10
minutes preincubation with lOmM unlabelled




A subsequent experiment (Figure 18) indicated that 
efflux of 1-deoxy-D-glucose from preloaded cells was 
accelerated by the addition of D-glucose externally.
This suggested a possible explanation of the uptake 
profile in that the internal D-glucose concentration 
which was thought to be very low inside the cells was 
in fact high enough to cause counter-flow and thus 
accumulation of 1-deoxy-D-glucose during uptake. This 
would, however, mean that transport was not rate- 
1imiting.
The above hypothesis was investigated by attempting 
to measure the internal D-glucose concentration using 
the glucose oxidase/peroxidase assay. The result of the 
assay was that no D-glucose could be detected internally, 
the internal concentraton being at least 20 times lower 
than the external D-glucose concentration. Such a low 
concentration could not be responsible for the 
accumulation of 1-deoxy-D-glucose by counter-flow thus 
disproving the above hypothesis.
4.2.3: Energy requirements for transport
The probable accumulation of 1-deoxy-D-glucose 
suggested that there may be an energy requirement for 
the transport process. To investigate this possibility 
the following experiment was devised:
Cells were preincubated at 37°C for sufficient time 
to deplete the level of ATP. A 3 minute preincubation
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Figure 18: Efflux of 50pM 1-deoxy-D-glucose vs. time
at 37°C (•). Efflux of 50pm 1-deoxy-D- 
glucose vs time with 2mM D-glucose in the 
external medium at 37°C (a ).
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time was found to be required to produce the maximum 
effect. This period of time corresponded to the time 
taken to accumulate the maximum label in the normal 
uptake time-course. After preincubation, the rate of 
uptake was measured. The results (Figure 19) indicated 
that the depletion of ATP caused an 11-fold drop in the 
initial rate of uptake. Also if D-glucose was 
reintroduced after preincubation and the cells allowed 
to recover for 10 minutes, the initial rate of transport 
of 1-deoxy-D-glucose was largely restored to previous 
zero-trans levels. This experiment suggested that either 
energy is required for the major component of transport
V
to occur, or that metabolism of the label was occurring 
and thus trapping the label in a reversible fashion. It 
was considered a possibility that the transport occurring 
after the preincubation period reflected the true non­
metabolised rate. This was further investigated but it 
was found that the transport was not saturable by high 
concentrations of cold analogue nor inhibited by 6-deoxy- 
or 2-deoxy-D-glucose.
Other analogues were investigated in terms of 
transport occurring before and after 3 minute preincubation 
periods. Figure 20 represents the time-courses of 3-0- 
methyl-D-glucose, 2-deoxy-D-glucose and D-galactose before 
and after preincubation. The figures show that both 3-0- 
methyl-D-glucose and 2-deoxy-D-glucose had reduced rates 
of uptake after preincubation, but D-galactose did not 
demonstrate such a change. As D-galactose is not 
metabolised and very probably not transported, the uptake
93
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Figure 19: Uptake of lOpM 1-deoxy-D-glucose at 37°C vs.
time after no preincubation (•), 3 minutes 
preincubation in buffer at 37°C (■), 3 
minutes preincubation at 37°C followed by 
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Figure 20: Uptake of A) ^C-3-0-methyl-D-glucose,
B) ^H-2-deoxy-D-glucose, C) ^C-D-galactose 
after 3 minutes preincubation (a ), or with 
no preincubation (•). All radio-labels 
were at 'tracer' concentrations.
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occurring after preincubation was concluded to be non­
specific leakage due to the loss of cell integrity.
This was also reflected in the low numbers of counts 
trapped when incubating the cells with radio-labelled 
D-galactose.
4.2.4: Thin layer chromatographic analysis of transported
analogues
To investigate the possibility of a group-translocase 
system being responsible for transport and subsequent 
phosphorylation of the analogue, a means of analysis of 
the transported analogue using thin layer chromatography 
(TLC) to measure the mobility of the sugar was devised 
(See Methods). Both labelled 1-deoxy-D-glucose and 2- 
deoxy-D-glucose were incubated with cells and the 
resulting sugar extracts spotted onto silica-gel plates. 
These were then developed in butanol:ethanol:water, 
(52:33:15). It was apparent from the results (Figure 21) 
that almost all transported label was altered and the use 
of standard sugars revealed the altered compounds to be 
the phosphorylated sugar derivative.
Previous time-courses had shown a period of efflux 
alter the peak of trapped label had been reached, so a 
further experiment was devised to determine whether the 
trapped phosphorylated sugar was. dephosphorylated prior 
to or during efflux, or that the efflux represented 
leakage of phosphorylated sugar due to loss of cell 
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Figure 21: Mobility of A) 1-deoxy-D-glucose, B)
2-deoxy-D-glucose on TLC plates before 
uptake - (O) and after uptake - (a ). TLC 
plates developed in Butanol:ethanol:water, 
(52:33:15).
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with labelled 1-deoxy-D-glucose for 30 seconds, washing 
the cells to remove all extracellular label, then 
resuspending the cells in buffer at 37°C and taking 
samples at various time points up to 10 minutes. The 
samples were centrifuged and the supernatant retained.
The pellet was washed twice and both the pellet and 
supernatant extracted for subsequent TLC analysis.
Figure 22 demonstrates clearly that the label within the 
cells was entirely in the phosphorylated form and its 
decrease during efflux was mirrored by an increase in 
free sugar outside the cells. No phosphorylated sugar 
was present outside the cells. From these results it was 
clear that the time-course for uptake represented a period 
of accumulation of phosphorylated 1-deoxy-D-glucose which 
continued until the source of the phosphate was depleted. 
The time taken to reach the peak sugar phosphate labels 
was similar to that of the loss of motility of the cells 
in the absence of substrate. The source of high-energy 
phosphate was assumed to be ATP.
As the rate of 1-deoxy-D-glucose efflux was slower 
than uptake, it was considered unlikely that 
dephosphorylation was occurring during efflux, but rather 
due to the action of a trypanosomal phosphatase activity.
The results from the hexokinase assay, indicating 
1-deoxy-D-glucose not to be a substrate for T. brucei 
hexokinase, suggested that the phosphorylation may have 
been carried out by some other means. It was however, 
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Figure 22: Efflux of 500pM 1-deoxy-D-glucose vs. time
at 37°C. The figure shows phosphorylated 
sugar remaining inside cells (a ) and free 
sugar appearance outside cells (•).
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for the kinetic analysis of sugar transport due to the 
high rate of phosphorylation occurring. The results with 
1-deoxy-D-glucose indicated that a truly non-metabolised 
analogue would be necessary to determine whether 
transport occurred prior to any subsequent metabolism.
It was at this stage that a concerted effort was 
made to synthesise labelled 6-deoxy-D-glucose (See 
Chapter 3). The eventual success of this effort 
indicated the need for improvements in the methodology 
of the uptake procedure when using 6-deoxy-D-glucose as 
a substrate for transport (See Chapter 4.3).
The resultant much reduced incubation time, lower 
temperature, and the greater effectiveness of the 
stopping solution was utilised when repeating experiments 
described in this section which analysed the state of 
transported analogues.
The results in Figure 23 indicate that, after a 
3 second incubation time, no 6-deoxy-D-glucose had 
been metabolised. Also, after transport of 1-deoxy-D- 
glucose, a significant proportion of the transported 
label was in the phosphorylated form. The high degree 
of phosphorylated sugar present after only 3 seconds 
incubation suggests a very rapid rate of phosphorylation 
by normally-metabolising trypanosomes. Further 
experiments were carried out where trypanosomes were 
preincubated for 10 and 20 minutes at room temperature 
to deplete the ATP levels in the cells. The proportion 




C P M  /  
108 Cells
1 0 0 0 -
400 20
DIST ( m m )
Figure 23: TLC analysis of 3 second uptake time-points
of 1-deoxy-D-glucose (o) and 6-deoxy-D- 
glucose (■) at 20°C. Peaks at 8mm 
correspond to sugar phosphate. TLC plates 
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Figure 24: TLC analysis of 3 second uptake time-points
of 1-deoxy-D-glucose (o) and 6-deoxy-D- 
glucose (■) at 20°C after 10 minutes 
preincubation without substrate. TLC plates 






5 0 0 -
200 40
D I ST . ( m m )
Figure 25: TLC analysis of 3 second time-points of
1-deoxy-D-glucose (o) and 6-deoxy-D-glucose 
(■) at 20°C after 20 minutes preincubation 
without substrate. TLC plates were developed 
in Butanol:ethanol:water, (52:33:15).
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The results (Figures 24 and 25) indicate that 
despite the depletion of ATP levels (no motility of 
trypanosomes) a high proportion of the transported 
1-deoxy-D-glucose was phosphorylated during a 3 second 
incubation period. This may have been indicative of 
an alternative reservoir of transferable phosphate.
The transport of 6-deoxy-D-glucose continued after the 
preincubation periods with no visible metabolism 
occurring although the total CPM transported decreased 
after 20 minutes preincubation in the absence of 
substrate. This probably represents a degree of energy 
starvation sufficient to deplete the population of 
viable cells despite the phosphorylation of transported 
1-deoxy-D-glucose.
4.2.5: 1-deoxy-glucose kinetic parameters
The changes made to the uptake assay procedure made 
possible a more accurate determination of the zero-trans 
entry kinetic parameters for 1-deoxy-D-glucose. Figure 
26b indicated that a time-course of lOOpM 1-deoxy-D- 
glucose did not follow saturation kinetics over a 60 
second time interval. Using the value for the internal 
volume of T. brucei cells accessible to analogue (Chapter
4.3.2), it can be seen that the accumulation of label is 
considerably above the expected equilibrium value for a 
non-metabolised analogue. The early part of the time- 
course did however, approximate to a normal uptake profile 
and the error in reduced backflux due to trapped 
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Figure 26: Uptake of lOOpM 1-deoxy-D-glucose vs.time.
A) at 37°C using the 1-deoxy-D-glucose uptake 
protocol (•), B) at 20°C using the later 6- 
deoxy-D-glucose uptake protocol (a). The 
broken line represents the calculated 
equilibrium value from 6-deoxy-D-glucose uptake. 
Uptake by both methods used lpl of radio-label 
per 5 x 107 cells.
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A single time point assay using an incubation time of 3
seconds was used to calculate the zero-trans entry
kinetic parameters as shown in Figure 27. The Km value
of 3.41 t 0.262mM for 1-deoxy-D-glucose uptake was
exactly the same as the for 1-deoxy-D-glucose
inhibition of 6-deoxy-D-glucose uptake (See Chapter
4.4.2). The V of 0.323 t 0.016mM sec  ^ was also max
similar to the V under zero-trans entry conditionsmax J
for 6-deoxy-D-glucose uptake (See Table 6 ). The 
similarity between the kinetic parameters of the two 
analogues suggests that both analogues use the same 
transport site.
Due to the high level of metabolism of 1-deoxy-D- 
glucose, it was not possible to use other standard kinetic 
approaches for the complete kinetic analysis of the 
T. brucei hexose transporter.
4.2.6: Inhibitors of 1-deoxy-D-glucose uptake
To further establish that only one transport pathway 
for both 1-deoxy-D-glucose and 6-deoxy-D-glucose was in 
operation in Trypanosoma brucei, simple percentage 
inhibition studies using a range of D-glucose analogues, 
were performed with both 1-deoxy-D-glucose and 6-deoxy- 
D-glucose as substrates for uptake. The results shown 
in Table 5 indicate the percentage inhibition, by a 20mM 
concentration of inhibitor, of the uptake of lOOpM 
substrate after 3 seconds incubation at 20°C. From 








Figure 27: Hanes plot of 1-deoxy-D-glucose uptake under
zero-trans conditions using a 3 second single
time-point assay at 20°C. K = 3.41 t 0.262m
mM, V = 0.323 t 0.016mM/sec, n = 4. Line
111 c l A.

























6-chi oro-6 -deoxy-D-glucose 95.4 95.2
Table 5: Percentage inhibition of lOOpM 6-deoxy-D-
glucose and 1-deoxy-D-glucose by a range of 
D-glucose analogues. Inhibition was measured 
using zero-trans conditions in a single time- 
point (3 second) uptake assay at 20°C.
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of binding to the sugar transport site was obtained.
There were no significant differences in the specificity 
of inhibition of 1-deoxy-D-glucose and 6-deoxy-D-glucose 
uptake. This result provides further evidence that both 
glucose analogues use the same transporter and this site 
is used by the normal substrates for T. brucei metabolism 
with the exception of glycerol.
4.3: 6-deoxy-D-glucose kinetic analysis
4.3.1: Transport assay conditions
When labelled 6-deoxy-D-glucose became available 
for transport experiments, initial studies were performed 
to determine whether transport of the analogue was 
occurring and whether the assay procedure previously 
used was suitable. Initial results indicated that 
transport of 6-deoxy-D-glucose by intact trypanosomes 
was occurring but the assay procedure, as used with 
initial 1-deoxy-D-glucose experiments, was not working 
sufficiently well to effectively trap transported label.
Time-course experiments indicated that equilibrium 
was reached much more rapidly by 6-deoxy-D-glucose but 
inhibition by saturating concentrations of unlabelled 
6-deoxy-D-glucose did not occur. It was concluded that 
the use of 5 volumes of ice-cold buffer as a stopper 
was not sufficient to prevent efflux of the non­
metabolised transported label during the wash procedure.
The use of the known inhibitor phloridzin (Gruenberg
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et al., 1978) as a potential stopping agent in conjunction 
with 20 volumes of ice-cold buffer was investigated and 
was found to be much more effective. A concentration 
of 2.2mM (0,lg/100ml) phloridzin was used as this 
concentration was stable in cold solution and effective 
as a stopper. Higher concentrations of up to 5mM were 
investigated but considerable heating of the buffer was 
required to dissolve the phloridzin and some 
recrystallisation occurred at 2°C. The higher 
concentrations of phloridzin also affected the pelleted 
trypanosomes rendering suspension much more difficult.
The final changes in the assay procedure were:
1. The change of stopper conditions and the 
subsequent reduction in volume of the reaction 
mixture. This allowed addition of stopper in 
an appropriately-sized reaction vessel.
2. Reduction of the assay temperature to 20°C from 
37°C.
3. An increase in the amount of labelled 6-deoxy- 
D-glucose used to compensate for the lower counts 
per minute at true equilibrium values.
4. A decrease in the assay incubation times when 
estimating initial rates of uptake due to the 
high rate of hexose transport.
With the parameters of the assay procedure determined, 
the effectiveness of the stopper containing phloridzin 
was compared with the use of cold buffer alone.
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Trypanosomes were preloaded with lOOpM labelled 6-deoxy- 
D-glucose until equilibrium was reached, then stopped 
by the addition of either 20 volumes of ice-cold buffer 
containing phloridzin, or 5 volumes of ice-cold buffer. 
After the appropriate incubation time the cells were 
processed as described in the protocol. The cells 
stopped with 5 volumes of buffer only, were further 
diluted with 15 volumes of ice-cold buffer containing 
an appropriate concentration of phloridzin to be 
equivalent to the normal stopper conditions.
The results shown in Figure 28 clearly indicate 
that the previous conditions used to stop uptake were 
insufficient to prevent leakage of trapped label even 
at temperatures of 0-2°C. The stopper containing 
phloridzin did prevent efflux of trapped label over the 
period of the time-course.
The processing of cells after incubation was 
stopped required a time of approximately 90 seconds 
which was well within the period of stability of the 
cells as indicated in Figure 28.
4.3.2: Determination of the intracellular water space
The improved uptake protocol and the use of a truly 
non-metabolised glucose analogue allowed the calculation 
of the intracellular water space for T. brucei from a 
time-course of 6-deoxy-D-glucose uptake. Such a time- 
course is shown in Figure 29. The result indicated that 
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Figure 28: Efflux of lOOpM 6-deoxy-D-glucose from
preloaded cells 'stopped' by addition of 
5 volumes of ice-cold buffer (•), or 20 
volumes of ice-cold buffer containing 1% 
phloridzin (2.2mM) (0).
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Figure 29: Time-course for uptake of lOOpM 6-deoxy-
D-glucose vs time at 20°C.
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a ’ti' of approximately 4 seconds. Equilibrium was 
2
reached after about 30 seconds and remained stable for 
several minutes.
Using the number of counts trapped at equilibrium 
and the specific radio-activity of the substrate, the 
intracellular volume accessible to the analogue was 
calculated as 1.19 t 0.13pl per 10^ cells (See Figure
g
30). The value is comparable to that of 1.7pl per 10 
cells calculated by Voorheis and Martin (1980), but is
g
much less than the value of 9.5pl per 10 cells determined 
by Damper and Patten (1976) who calculated the volume of 
liquid displaced by the total pellet of the cells.
The use of a non-transported labelled marker to 
determine the proportion of counts in the extracellular 
space of the pellet was not considered necessary as the 
counts in the zero-time determinations were very low 
due to the large relative volume of the stopping solution 
used to wash the cells.
4.3.3: Zero-trans entry experiments
The determination of kinetic constants for
zero-trans entry experiments was initially carried out
using a single time-point assay at each appropriate
concentration. The time-point used was 4 seconds as
this gave a reasonable estimate of the initial rate of
uptake. The results obtained were K = 2.16 t 0.068mM, r m
Vmax = 0*27 t 0.006mM sec  ^ (Figure 31).
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Concentration of 6-deoxy-D-glucose
Total radio-activity added to the 
assay
(lOpl of lmM 6-deoxy-D-glucose) 
Total volume of the assay
Therefore:
Counts per minute per pi of 
extracellular volume
o
At equilibrium, uptake by 10 cells
Q







Figure 30: Example of a calculation of the intracellular
space accessible to lOOpM 6-deoxy-D-glucose.
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Figure 31: Hanes plot of 6-deoxy-D-glucose uptake
under zero-trans conditions using a 4
second single time-point assay at 20°C.
K = 2.16 + 0.068mM, V = 0.279 + m max
0.005mM sec ^, n = 6 . Line fitted by
method of least squares.
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The zero-trans uptake parameters were also 
determined using complete time courses at each 
concentration of 6-deoxy-D-glucose. It was apparent 
from the time-courses (Figures 32 - 36 insets) that a 
4 second time point would give a significant under­
estimate of the initial rate of uptake especially at 
lower concentrations and calculated initial rates would 
provide more accurate kinetic parameters for zero-trans 
uptake.
The calculation of the initial rate used the
integrated rate procedure as described by Eilam and
Stein (1973). According to this procedure t/C is plotted
against -(In (1 - C/SQ ) + C/SQ )/C where t is the time
of uptake, C is the internal substrate concentration
and S is the external substrate concentration. The o
integrated rate plots were linear (Figures 32 - 36) and
the initial velocity was obtained as the reciprocal of
the intercepts on the ordinate axis. Figure 37 shows
a plot of S/V vs S for the calculated initial velocities.
The zero-trans entry kinetic parameters were: = 1.54
- 0.28mM, V = 0.401 t 0.04mM sec These values max
differed from those obtained using the single time-point 
assay procedure in that the Km value was 27% higher 
and the maximum velocity was 31% lower.
4.3.4: Zero-trans exit experiments
The determination of the kinetic parameters of the 
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Figure 32: Integrated rate replot of lOOpM 6-deoxy-D-
glucose. Initial rate (V ) calculated as 
0.024 - O.OOlmM sec ^. Line fitted by method 
of least squares. Inset: Time-course for
lOOpM 6-deoxy-D-glucose uptake at 20°C. C 
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Figure 33: Integrated rate replot of ImM 6-deoxy-D-
glucose. V = 0.150 t 0.003mM sec ^. Line ° o
fitted by method of least squares. Inset: 
Time-course for ImM 6-deoxy-D-glucose 
uptake at 20°C. C is the concentration 
inside the cells.
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Figure 34: Integrated rate replot of 2mM 6-deoxy-D-
glucose. VQ = 0.292 1 0.013mM sec'1. Line 
fitted by method of least squares. Inset: 
Time-course for 2mM 6-deoxy-D-glucose 
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Figure 35: Integrated rate replot of 5mM 6-deoxy-D-
glucose. VQ = 0.292 t 0.013mM sec”1. Line 
fitted by method of least squares. Inset: 
Time-course for 5mM 6-deoxy-D-glucose uptake 
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Figure 36: Integrated rate replot of lOmM 6-deoxy-D-
glucose. VQ = 0.337 t 0.047mM sec"1. Line 
fitted by method of least squares. Inset: 
Time-course of lOmM 6-deoxy-D-glucose 
uptake at 20°C. C is the concentration 
inside the cells.
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Figure 37: Hanes plot of 6-deoxy-D-glucose uptake under
zero-trans conditions at 20°C using the 
initial rates calculated from the integrated 
rate replots of uptake time-courses. Km ,
1.54 + 0.275, Vmax = 0.401 + 0.039mM sec". 
Line fitted by method of least squares.
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zero-trans exit procedure. A series of efflux time- 
courses were carried out at different 6-deoxy-D-glucose 
concentrations and all the data were analysed using the 
integrated rate procedure of Karlish et al., (1972).
The following equation is arranged in the form of a 
Lineweaver-Burk transformation of the Michaelis-Menten 
equation:
zero, and St is the intracellular sugar concentration at 
time t.
The data shown in Figure 38 represent the efflux
time-courses which were replotted using the integrated
rate equation as shown in Figure 39. The fitted line
was extrapolated to the x and the y axes and the
reciprocals calculated to give the following kinetic
parameters: K = 2.76 ± 0.33mM and V = 0.279 t 0.02mMr m max
sec  ^ . These results are similar to the values obtained 
for the zero-trans entry experiments and suggest that the 
hexose transport system is symmetrical in its binding 
site structure.
There were some technical problems with the zero-trans 
exit procedure due to the low internal volume of the 
trypanosomes accessible to the analogue. The cells were 
preloaded with 6-deoxy-D-glucose until equilibrium was 
reached, followed by a 50-fold dilution in buffer. These




where SQ is the intracellular sugar concentration at time
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Figure 38: Efflux of 6-deoxy-D-glucose at 20°C from
cells preloaded with radio-label for 5 
minutes (•) - lOmM, (O) - 5mM, (■) 2mM, 
(A ) - ImM 6-deoxy-D-glucose.
- In St/ S 0
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Integrated rate replot of efflux of 6-deoxy-
D-glucose at 20°C. (•) - lOmM, (o) - 5mM,
(■) - 2mM, (a ) - ImM. Km = 2.76 t 0.33mM,
V = 0.28 t 0.02mM sec ^. Line fitted by max J
method of least squares.
126
factors resulted in low CPM values, few cells per pellet 
and very high cell concentrations when loading with 
labelled analogue. It was not feasable to increase the 
initial cell concentration further so great care was 
taken during the final wash procedures not to inadvertently 
dislodge and remove the small pellet present.
The possible effect of the difficulties in the 
procedure should be noted when interpreting the results.
4.3.5: Equilibrium exchange experiments
The kinetics of the hexose transport system were 
further investigated using the equilibrium exchange 
procedure. Cells were preloaded with a range of 
concentrations of unlabelled 6-deoxy-D-glucose followed 
by the addition of equivalent concentrations of labelled 
6-deoxy-D-glucose and the flux of the label was measured.
Initially, a time-course of the uptake of ImM 
6-deoxy-D-glucose under equilibrium exchange conditions 
was carried out (Figure 40 inset). Under these conditions 
where no net flux of the analogue occurred, the time- 
course was found to approximate to a simple exponential 
curve. This was confirmed by fitting the data to the 
following equation:
The resulting replot (Figure 40) produced a straight
0 10
t ( s e c )
20
Figure 40: Log plot of ImM 6-deoxy-D-glucose uptake
at 20°C under equilibrium exchange 
conditions. The figure indicates the 
exponential nature of the time-course 
shown in the inset.
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line passing through the origin.
Due to the simple exponential nature of the uptake 
profile, an estimate of the initial rate of uptake at a 
particular 6-deoxy-D-glucose concentration could accurately 
be obtained with any single time-point using the 
relationship:
V = -In (1 - f) . S o o
where f is the fractional filling and S the outside° o
substrate concentration.
The kinetic parameters for 6-deoxy-D-glucose under
equilibrium exchange conditions were obtained using the
above relationship and a 4 second single time-point
uptake assay. The data was plotted using a Hanes plot
(Figure 41) and fitted using the method of least squares.
The kinetic parameters obtained were: K = 2 . 3 9r m
t 0.41mM and V = 0.755 t 0.084mM sec These max
values are again similar to those previously obtained 
reinforcing the evidence for a symmetrical carrier 
although the maximum velocity was significantly higher 
than that for zero-trans entry and exit.
Figure 42 shows the time-courses for ImM 6-deoxy- 
D-glucose uptake under both equilibrium exchange and 
zero-trans entry conditions. The result shows that 
both time-course profiles are virtually superimposable 





Figure 41: Hanes plot of 6-deoxy-D-glucose uptake vs.
concentration at 20°C under equilibrium
exchange conditions using a 4 second single
time-point. K = 2.39 t 0.41mM, V = r m _, max
0.76 1 0.08mM sec , n = 4. Line fitted 
by method of least squares
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Figure 42: Time-course for uptake of ImM 6-deoxy-D- 
glucose under equilibrium exchange 
conditions (•) and zero-trans conditions 
(a ) at 20°C.
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4.3.6: Infinite cis experiments
A further indication of the K for the inside sitem
was obtained using the infinite cis entry procedure.
The concentration of substrate used was 40mM 6-deoxy-D- 
glucose, this being well above the Km observed for the 
zero-trans entry experiment. The concentration was thus 
effectively infinite on the cis side of the transporter.
Figure 43 inset shows a time-course for uptake of 
6-deoxy-D-glucose at a 40mM concentration.
The integrated rate equation of Eilam and Stein 
(1974) was applied to the time-course and the 
appropriate replot gave a straight line shown in 
Figure 43.
The intercept on the ordinate axis gave 1/V^ ° max
and the intercept on the abscissa was equal to
2
-K /S (1+S / 7r ) where r is the effective osmotic m o  o
concentration of the medium. The osmotic concentration
of the KRP buffer and the substrate was 302 mOsM and
the kinetic parameters were: K = 6.21 t 1.20mM andr m
V = 0.601 - 0.052mM sec The K value is max m
significantly higher than values obtained in the 
prevous kinetic experiments.
This could be explained by the length of incubation 
of the cells at the later time-points causing an element 
of leakage. Also a much lower concentration (50pM) of 
label was used to determine the equilibrium value for 
the experiment. Any small error in this value or others
132
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Figure 43: Integrated rate replot of 40mM 6-deoxy-D-
glucose. Infinite cis kinetic parameters:
K = 6.21 + 1.20mM, = 0.601 1 0.052mM
t max
sec . Osmolarity = 302 mOsM. Line fitted 
by method of least squares. Inset: Time-
course of 40mM 6-deoxy-D-glucose under 
infinite cis conditions at 20°C.
KINETIC PROCEDURE NUMBER OF DETERMINATIONS AFFINITY CONSTANT Km
mM
MAXIMUM VELOCITY (V ) , max
mM sec
Zero-trans entry 6 1.57 ± .28 0.40 ± .04
Zero-trans exit 4 2.76 + .33 .28 + .02
Equilibrium exchange 
entry
4 2.39 ± .41 .76 + .08
Infinite cis entry 4 6.21 ± 1.20 .601 + .052
Table 6 : Summary of the kinetic parameters of 6-deoxy-D-glucose transport in T. brucei at 20°C.
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in the experiment would have a disproportionate effect on 
the calculation due to the square function in the equation.
4.3.7: Summary of kinetic parameters
The kinetic parameters for K and V using the r m max °
approaches described previously are summarised on Table 
6 .
4.4: Specificity of hexose transport in T. brucei
The specificity of hexose transport in T. brucei 
was analysed using a series of inhibitors of 6-deoxy- 
D-glucose transport. The aim was to obtain inhibition 
constants (K^'s) for a range of analogues at each 
hexose carbon position, investigating both the spatial 
and hydrogen bonding requirements of the transporter 
binding site. values were calculated using a range
of inhibitor concentrations at a fixed lOOpM 6-deoxy- 
D-glucose concentration. The results were plotted on a 
Hanes plot and fitted by the method of least squares.
When inhibition was less than 10% of the initial rate 
of 6-deoxy-D-glucose uptake at the highest inhibitor 
concentration (20-24mM), the value was described as 
greater than 250mM.
Initial experiments were performed to determine 
whether preincubation with inhibitor or simultaneous 
addition of inhibitor would be most appropriate for the 
assay procedure. The problem with preincubation is that 
substrates or metabolised substrate analogues would not
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reach true equilibrium and the resultant depletion of 
energy caused by partial metabolism of substrate 
analogues could affect the rate of transport or the 
action of the inhibitor.
The effect of preincubation was investigated using 
2-deoxy-D-glucose, a substrate analogue known to be 
rapidly transported and phosphorylated but not further 
metabolised (Gruenberg et al. , 1978). 2-deoxy-D-glucose 
was preincubated with cells at 20°C for 3 minutes prior 
to 6-deoxy-D-glucose addition. The value obtained 
was compared to that produced by simultaneous addition 
of substrate and inhibitor. The result (Figure 44) 
indicated that preincubation had little significant 
effect on the value for 2-deoxy-D-glucose. The 
small decrease in affinity shown by the inhibitor 
after preincubation was probably accounted for by the 
overall drop in inhibitor concentration caused by 
phosphorylation of transported 2-deoxy-D-glucose.
The above experiment was repeated using 1-deoxy-D- 
glucose as an inhibitor and surprisingly no significant 
inhibition occurred after the 3 minute preincubation 
period even at concentrations up to 200 times the 
6-deoxy-D-glucose concentration. Simultaneous 
addition of inhibitor and substrate did produce a 
sensible value. Although there was no obvious 
explanation for the result, it did suggest that 
simultaneous addition of substrate and inhibitor would 
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Figure 44: Inhibition of lOOpM 6-deoxy-D-glucose uptake
by 2-deoxy-D-glucose without preincubation 
(0 ) and with 3 minutes preincubation at 20°C 
(•), = 0.53 t 0.08mM, n = 2, (no
preincubation) and = 0.63 1 0.07mM, n = 2,
(3 minutes preincubation). Inhibition 
measured with a 3 second single time-point 
assay. Lines fitted by method of least squares.
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4.4.1: Inhibition of 6-deoxy-D-glucose uptake by
substrates of T. brucei metabolism
The natural substrates of T. brucei metabolism, 
D-glucose, D-fructose, D-mannose and glycerol, were used 
as inhibitors of 6-deoxy-D-glucose uptake. Glycerol 
did not significantly inhibit uptake indicating that the 
hexose transporter has no ability to transport glycerol 
and its uptake must be via a totally separate transport 
system.
Figure 45 indicates the values for the other 
substrates to be: 0.899 t 0.077mM for D-glucose,
0.670 t O.lOOmM for D-mannose and 2.560 t 0.004mM for 
D-fructose. The results indicate that the natural 
substrates all have a high affinity for the transporter 
binding site. D-fructose has a significantly lower 
affinity than D-mannose and D-glucose.
4.4.2: Inhibition by carbon-1 analogues
The carbon-1 analogues used were 1-deoxy-D-glucose,
0-f luoro-D-glucose and oc-methyl-D-glucoside. Prior to 
use, @-fluoro-D-glucose was prepared from /3-D- 
glucopyranosyl-fluoro-tetracetate by the addition of 
lOmM sodium methoxide followed by incubation at room 
temperature for 2 hours. Previously calculated aliquots 
of the solution were dispensed into vials and the methanol 
removed by evaporation. Immediately prior to use, lOpl of 
buffer was added to the vial to give the correct 






Figure 45: Inhibition of lOOpM 6-deoxy-D-glucose uptake
by D-mannose (•), = 0.67 t O.lOmM, n = 2,
D-glucose (o), = 0.90 t 0.04mM, n = 2 and
D-fructose (±), = 2.56 t 0.40mM, n = 2.
Lines fitted by method of least squares.
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The pH of the solution was neutral as determined using 
pH indicator paper.
Figure 46 indicates values of 2.89 t 0.63mM and 
3.65 - 0.43mM for @-fluoro-D-glucose and 1-deoxy-D- 
glucose respectively. The value for a-methyl-D- 
glucoside was found to be greater than 250mM. Similarity 
of the values for the deoxy- and the deoxy-fluoro- 
analogue indicate that there is no requirement for a 
hydrogen bond involving the carbon-1 hydroxyl group.
The lack of inhibition by ot-methyl-glucoside suggests 
that there is a close approach to the transport binding 
site and thus very little room for potential substitution 
at the carbon-1 position.
4.4.3: Inhibition by carbon-2 analogues
The specificity study at the carbon-2 position 
used the analogues 2-fluoro-2-deoxy-D-glucose, 2-deoxy- 
D-glucose, D-glucosamine and N-acetyl-D-glucosamine as 
inhibitors of 6-deoxy-D-glucose uptake.
The values obtained were 0.44 t 0.09mM for
2-fluoro-2-deoxy-D-glucose, 0.53 t 0.08mM for 2-deoxy- 
D-glucose, 21.34 t 3.68mM for D-glucosamine and 11.11 
t 1.78mM for N-acetyl-D-glucosamine as shown in Figures 
47 and 48.
The values from the deoxy- and the deoxy-fluoro- 
analogues indicate that no hydrogen bond involving the 
carbon-2 hydroxyl group occurs. The larger carbon-2 
substituted analogues indicate that there is considerable
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spatial freedom around the carbon-2 position. The 
higher affinity shown by N-acetyl-D-glucosamine compared 
with D-glucosamine may be indicative of a hydrophobic 
region in the vicinity of carbon-2. Further spatial 
freedom at the carbon-2 region of the transport site is 
indicated by the high affinity shown by the substrate 
D-mannose, the C-2 epimer of D-glucose. However, 
mannitol, an analogue existing only in the straight chain 
configuration, did not inhibit 6-deoxy-D-glucose uptake. 
This suggests that a closed ring structure may be 
necessary for binding.
4.4.4: Inhibition by carbon-3 analogues
The carbon-3 (C-3) position was analysed using the 
analogues 3-0-methyl-D-glucose, 3-fluoro-3-deoxy-D- 
glucose, 3-deoxy-D-glucose and the C-3 epimer of D- 
glucose, D-allose.
Neither the 3-deoxy-D-glucose nor D-allose 
significantly inhibited 6-deoxy-D-glucose uptake but
3-fluoro-3-deoxy-D-glucose did inhibit giving a value 
of 2.31 t 0.34mM (Figure 46). The results indicate that 
the C-3 hydroxyl group is involved in a hydrogen bond 
necessary for binding to the hexose transporter. The 
removal of the hydroxyl-group from the correct 
orientation, ie using 3-deoxy-D-glucose and the C-3 
epimer allose as inhibitors, results in a complete loss 
of affinity. The fluoro-group, which can still 
participate in hydrogen bonding, only results in a
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slight loss of affinity. 3-0-methyl-D-glucose inhibited 
6-deoxy-D-glucose uptake giving a of 15.38 t 0.86mM 
(See Figure 48). The methyl group indicated a degree of 
spatial freedom at the C-3 position provided the hydrogen 
bond can still form. The methyl group did not 
significantly interfere with the formation of this bond.
4.4.5; Inhibition by carbon-4 analogues
Only limited analysis was performed at the 
carbon-4 (C-4) position due to the difficulty in 
synthesising fluoro- and deoxy- analogues at this 
position. The C-4 epimer D-galactose was found not to 
inhibit uptake nor did 4,6-ethylidine-D-glucose although 
this sugar is a C-4/C-6 analogue. Without information 
from the deoxy- and deoxy-fluoro- analogues, no 
conclusions as to hydrogen-bonding requirements could 
be drawn. The lack of inhibition by D-galactose 
suggests that there is either a very close approach to 
the binding site at the C-3 position, or a hydrogen 
bond is necessary, or that both these conditions must 
be satisfied for binding to occur.
4.4.6: Inhibition by carbon-5 analogues
The sole carbon-5 (C-5) analogue, 5-thio-D-glucose 
did inhibit uptake with a of 11.67mM as shown in 
Figure 49. This would indicate that the replacement of 
the ring oxygen with a sulphur atom does reduce the
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affinity of the analogue for the binding site. Hydrogen 
bonding may occur with the ring oxygen but is not 
essential for binding to the hexose transporter.
4.4.7: Inhibition by carbon-6-analogues
The effectiveness of 6-deoxy-D-glucose as a 
substrate for the hexose transporter has already been 
established. This indicates that a hydrogen bond 
involving the carbon-6 (C-6 ) hydroxyl group is not 
necessary for binding and transport to occur. The 
analogue 6-fluoro-6-deoxy-D-glucose was not available 
for study but 6-chloro-6-deoxy-D-glucose had been 
synthesised and was used as an inhibitor. Figure 47 
indicates a value of 0.67 t 0.09mM. The analogue 
D-xylose did not however inhibit uptake indicating that 
the carbon at position 6 is necessary for effective 
binding to the transporter.
No analogues were available to investigate the 
spatial characteristics around carbon-6 .
4.4.8: Other analogues
The previous sections account for all the analogues 
tested as inhibitors of 6-deoxy-D-glucose uptake except 
the disaccharide, maltose. Figure 49 indicates that a 
of 16.46mM was determined. It is surprising that 
maltose inhibits 6-deoxy-glucose uptake as maltose, 




f I ] mM
Figure 46: Inhibition of lOOyM 6-deoxy-D-glucose uptake
by 0-fluoro-D-glucose (a ), = 2.89 t 0.63mM,
n = 2, 1-deoxy-D-glucose (•), = 3.65 t
0.43mM, n = 2 and 3-fluoro-3-deoxy-D-glucose 
(a ), = 2.31 t 0.34mm, n = 2. Lines
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Figure 47: Inhibition of lOOyM 6-deoxy-D-glucose uptake
by 2-deoxy-D-glucose (•), = 0.530 t
0.078mM, n = 2. 2-fluoro-2-deoxy-D-glucose
(a ), k. = 0.444 t 0.085mM, n = 2. 6-chloro-l
6-deoxy-D-glucose (O), = 0.670 t 0.090mM,
n = 2. Lines fitted by method of least 
squares.
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Figure 48: Inhibition of lOOpM 6-deoxy-D-glucose uptake
by D-glucosamine ( O ) ,  = 21.34 t 3.68mM,
n = 2. 3-0-methyl-D-glucose (A ), =
15.38 t 0.86mM, n = 2. N, acetyl-D- 
glucosamine (•), = 11.11 1 1.78mM, n = 2.





Figure 49: Inhibition of lOOpM 6-deoxy-D-glucose uptake 
by 5-thio-D-glucose (•), = 11.67 t 0.94mM
Maltose (A ), = 16.46 I 1.93mM,n = 2 .
n = 2. Lines fitted by method of least 
squares.
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4-glycosidic bond, is either a C-l or C-4 analogue of 
D-glucose, both of which are positions demonstrated to 
have little or no spatial freedom. It is possible that 
the disaccharide binds in a different fashion still 
inhibiting uptake of 6-deoxy-D-glucose.
Another explanation may be the effect of D-glucose 
impurities in the commercial compound. D-glucose 
contamination of 170 is usual and, at the concentration 
range used, D-glucose may have been present in 
sufficiently high concentrations to account for all the 
inhibition shown in the plot.
4.4.9: Summary of the specificity study
Table 7 indicates the results of all inhibition 
studies on the uptake of 6-deoxy-D-glucose and 
represents the complete specificity analysis as allowed 
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1.54 ± 0.28* 
0.67 ± 0.09 
>250
* K not K. m 1
Table 7: Inhibition constant (K^) values for a range of
D-glucose analogues determined by inhibition of 




The transport of sugars into trypanosomes, though 
clearly an important step in the production of metabolic 
energy, has received very little previous attention. 
Gruenberg et al., (1978) stated that the transport process 
was the rate-limiting step in the glycolytic pathway, the 
sole source of energy in bloodstream-forms of T. brucei.
If this is the case then transport of hexoses is potentially 
even more important, representing a prime target for the 
action of trypanocidal agents.
Regulation of the glycolytic flux does not appear to 
be under enzymic control. Of the classical regulatory 
enzymes, neither hexokinase, phosphofructokinase (Nwagu 
and Opperdoes, 1982) nor pyruvate kinase (Flynn and 
Bowman, 1981), have been found to regulate glycolysis in 
T. brucei. The hypothesis that the permeation process is 
rate-limiting has come about almost by default. The 
conclusions of Gruenberg et al., (1978) were based on 
indirect evidence of assays which measured steady-state 
uptake rates rather than initial rates, and non-metaboli- 
sable substrates were not used. These results indicate 
that permeation proceeded at a rate slower than 
metabolism. The transport rate was given as 21nmol/min/
Q
10 cells. It is difficult to see how metabolism of 
D-glucose can occur at the described rate when permeation 
proceeds maximally at a rate 4 times more slowly. This 
suggests that a significant underestimate of the transport 
flux has been made.
One of the aims of the work in this thesis has been
to develop suitable transport protocols which, by
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specifically measuring the rate of substrate transport 
in trypanosomes» can clarify the rate-1 imitinig properties 
of the tran;slo<cation step. Initially, studies were 
centred on the poorly metabolised D-glucose analogue,
1-deoxy-D-glucose ( Game e t a 1. , 19;86) . Although useful 
kinetic parameters for Influx were obtained, attempts 
to characterise efflux and exchange kinetics and carry 
out inhibition studies were complicated by a significant 
phosphorylation of the analogue by intact trypanosomes. 
This is in contrast to the studies using 1-deoxy-D- 
glucose as a substrate for trypanosoma! hexokinase in 
vitro where no phosphorylation was detected (See Section 
4.2.1)., This also raised questions on the method of 
phosphorylation of transported substrates which will be 
discussed later. Early studies showed that 6 -deoxy-D- 
glucose was an effective inhibitor of 1-deoxy-D-glucose 
uptake. Since 6 -deoxy-D-glucose cannot be metabolised,, 
it was considered an important analogue for the study 
of transport. A.s this analogue is not available 
commercially as a radio-label, the synthesis of tritiated 
6-deoxy-D-glucose was regarded as essential to the 
success of these studies.
5.1: Synthesis of radio-labelled 6 -deoxy-D-glucose
Initially, tritiated lithium aluminium hydride 
(LiAdH^) was used as the means for incorporating radio­
activity into the substrate analogue. This involved the 
synthesis of 6-chloro-6 -deoxy-^-methyl-D-glucoside,
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protection of free hydroxyl groups and exchange of
chlorine with tritium from tritiated LiAlH^ (Section 3.1).
Only one attempt at this radio-labelling step was possible
3
due to the withdrawal of commercially available H-LiAlH^. 
However, on the evidence of this one attempt, any further 
effort may have been equally unsuccessful. LiAlH^ is 
inherently unstable and the long shipment time may have 
accentuated problems with the decomposition of the radio­
label. It was apparent from the manufacturers that 
problems in supply of stable labelled LiAlH^ was 
responsible for the withdrawal of the product from the 
market.
The alternative and more expensive radio-labelling
procedure involved the exchange of halogen with tritium
gas over a palladium catalyst (Amersham procedure Tr-3).
The precursor recommended by Amersham for the tritium
labelling was 6-iodo-«.-methyl-D-glucoside. This was
because the iodo- group is the halogen which exchanges
most readily with tritium in the presence of the catalyst.
The previous approach using a protected chloro-glucoside 
3
and H-LiAlH^ for the synthesis of labelled 6-deoxy-D- 
glucose may, therefore, have been more successful if a 
protected iodo-glucoside had been synthesised and used 
rather than a chloro-compound.
The Tr-3 procedure did not require the protection 
of free hydroxyl groups, however, the investigation in 
this thesis of suitable methods for protecting hydroxyl 
groups may be useful for future work involving the
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synthesis of C-6 sugar analogues.
Initial attempts to synthesise the 6-iodo derivative 
used two methods, both of which were unsuccessful.
Direct halogenation of sugars using N-iodo succinimide 
to iodinate oc-methyl-D-glucoside in the presence of 
triphenyl phosphine as described by Hanessian and Lavallee, 
(1976) was not successful although they described similar 
reactions which proceeded with high yield. The second 
method, involving tosylation of the C-6 hydroxyl group 
followed by replacement with iodine from sodium iodide, 
failed to yield a single readily purifiable product 
although there is no reason why the reaction should not 
be successful if sufficient time were spent optimising 
the reaction conditions. The availability of previously 
synthesised 6-Chloro-oc.-methyl glucoside provided an 
alternative means for synthesis of the iodo-compound by 
halogen exchange with sodium iodide. This simple reaction 
worked well, yielding a single easily-purified product.
The subsequent radio-labelling produced a very large 
quantity of methyl-6-deoxy-D-glucose of high specific 
activity and, in terms of the radio-chemical yield, was 
highly successful and cost effective.
5.2: Kinetics of 6-deoxy-D-glucose transport
The transport of 6-deoxy-D-glucose into trypanosomes 
was found to be extremely rapid at 37°C and it was 
necessary to reduce the temperature for the kinetic 
characterisation to 20°C. At this temperature the design
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and execution of protocols to measure both uptake and
efflux were feasible. From the equilibrium values
obtained for 6-deoxy-D-glucose uptake, the water space
available to the analogue was calculated as 1.19 ±
8 *0.13pl per 10 cells.. This value is comparable to that 
of Voorheis and Martin, (1980) of 1.75pl per 10^ cells, 
but was considerably lower than the value of 9.5yl
Q
per 10 cells determined by Damper and Patten, (1976). 
This latter value was used by Gruenberg et al., (1978) 
to calculate internal concentrations of D-glucose and
2-deoxy-D-glucose after transport had occurred. These 
calculations will have been considerably affected by 
the overestimate of the value for the internal cell
o
volume. The internal volume of 5.9pl per 10 cells as
reported by us (Game et al., 1986) using 1-deoxy-D-
glucose was in error due to the trapping of some of the
radio-label as sugar phosphate.
The values of the kinetic parameters calculated
from both the zero-trans entry and exit experiments were
similar. This suggests that a symmetrical carrier is
operative in T. brucei. This is confirmed by the results
from the equilibrium exchange procedure, as time-courses
for uptake under exchange and zero-trans conditions
were superimposable using ImM substrate. Kinetic
parameters were also similar although the V for r , ° max
exchange (0.755 - 0.084mM sec ^) is significantly higher 
than that calculated under zero-trans condiitons (0.401 
t 0.04mM sec ^). This suggests that the symmetrical
transport system shows slightly accelerated exchange 
n = 6 .
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although this is only clearly evident at high 
concentrations. The parameters obtained from the infinite 
cis entry protocol were also similar to those obtained 
using the other procedures. The variation seen between 
the different kinetic parameters is not uncommon in other 
transport systems (See Tables 8 and 9) and may reflect 
either the deviation of a particular transport system from 
the simple carrier model or simply the technical 
difficulties associated with the experimental protocols 
themselves.
Other mammalian transport systems have generally
been classified as symmetrical or asymmetrical carrier
systems. Tables 8 and 9 summarise the kinetics of
several mammalian sugar transporters. The human
erythrocyte was one of the first and most extensively
studied transport systems, but its kinetics are still not
understood. The important kinetic features are that
asymmetric transport rates are evident. Zero-trans entry
is characterised by a low K and V whilst zero-transJ m max .
exit protocols show a high K and V . However, underr & m max *
infinite cis entry conditions which measure the inside 
site, a low Km is apparent (Baker and Naftalin, 1979). 
These results suggest that a simple carrier model is 
unable to explain the kinetics of human erythrocyte 
hexose transport. Asymmetric kinetics have also been 
shown by human lymphocyte hexose transport (Rees and 
Gliemann, 1985) although the degree of asymmetry is much 
less pronounced. The latter experiments were carried out 
at 37 C whilst most erythrocyte experiments were performed
CELL TYPE HUMAN ERYTHROCYTE HUMAN LYMPHOCYTE RAT THYMOCYTE .6
SUBSTRATE D-glucose 3-0-methyl-D-glucose 3-0-methyl-D-glucose
K (mM) m Vmax 
(mM/sec)
K (mM) m Vmax 
(mM/sec)




.60 4.5 .72 7.7 .011
Zero-trans
exit 2.5 2
2.15 12.9 .22 - -
Equilibrium 
exchange 3.4 3
6.00 11.4 .69 25.0 .035
Inf inite 
cis entry 2.8 , 4
- 1.5 .65 - -
Table 8 : Kinetic parameters of mammalian hexose transport systems showing asymmetric
kinetics. References: 1) Lacko et al., 1972, 2) Karlish et al., 1972,
3) Naftelin and Holman, 1972, 4) Hankin et al., 1972, 5) Rees and Glieman, 
1985, 6 ) Whitesell e t a l ., 1977.






K (mM) m Vmax 
(mM/sec)





entry 5.41 0.034 6.10 1.20 20.5
1.37
Zero-trans
exit 4.09 0.153 2.66 1.19 21.6 1.53
Equilibrium 
exchange 4.22 * 0.058 4.45 0.84 19.0
1.47
Infinite 
cis entry 9.03 0.006 6.51 0.98
- -
Table 9: Kinetic parameters of mammalian hexose transport systems showing symmetrical
kinetics. Reference: 1) Taylor and Holman, 1981, 2) Craik and Elliot, 1979.
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at 25°C. However, it seems likely that kinetic asymmetry
shown is also expressed at 37°C although the Km values for
zero-trans exit and equilibrium exchange are lower,
(Brahm, 1983). Table 9 lists the kinetic parameters for
the rat adipocyte and hepatocyte hexose transport systems.
The K and V values shown are similar to the kinetic m max
parameters for T. brucei hexose transport (See Table 6 ).
The rat adipocyte transports hexose rapidly by
facilitated diffusion (Crofford and Renold, 1965a, b).
Since D-glucose is rapidly metabolised, studies have been
performed using the analogue 3-0-methyl-D-glucose. The
rate of transport is markedly increased in the presence
of insulin and a number of investigations have suggested
that the increase in V is brought about by themax ° J
redistribution of transporter between the plasma membrane
and an internal storage site (Cushman and Wardzala, 1980) .
The V for transport after insulin stimulation is max r
similar to the V for trypanosomal hexose transportmax Jr ^
(Table 6 ). It is clear that on the basis of kinetic 
studies, hexose transport in T. brucei falls into the 
same category as adipocytes and hepatocytes in that they 
display symmetrical transport parameters. The role of 
rapid transport of hexose into adipocytes is clear, 
allowing removal of D-glucose from the bloodstream for the 
storage of energy reserves in the form of fat. This is 
not true for the erythrocyte which shows little D-glucose 
metabolism and in which the role of the high capacity 
transport system remains largely unknown.
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In order to compare the kinetic values for 6-deoxy-D-
glucose transport in T. brucei with those reported by
other workers using different species and sub-species of
trypanosomes, it was necessary to recalculate V values J r J max
in terms of concentration per second. These calculations
used the value for the internal volume of T. brucei
determined in this work. The assumption was made that the
internal volume of other species of trypanosomes was
similar to that of T. brucei. This would be true for
T. b. gambiense as it is morphologically indistinguishable
from T. brucei but this may not be so for T. equiperdum
although a significant difference is unlikely.
The V of 0.401 + 0.04mM sec  ^ for 6-deoxy-D-glucose max “ j o
calculated from zero-trans uptake procedures at 20°C is
significantly higher than the corresponding V of 0.29mMrnsx.
sec  ^ calculated by Gruenberg et al. (1978) for D-glucose 
uptake at 37°C in T. brucei. It is not surprising that 
the rate of uptake is underestimated under steady-state 
conditions as backflux may reduce the internal substrate 
concentration. Also, efflux of radio-labelled pyruvate, 
the product of D-glucose metabolism under aerobic 
conditions, may occur. This loss of internal radio-label 
may occur throughout the incubation period and after the 
transport process has been 'stopped'. It has been shown 
(Figure 28) that stopping transport with cold buffer alone 
is insufficient to prevent efflux of substrate and 
presumably pyruvate and thus a considerable proportion of 
transported radio-label will have been lost during the 
long (10-20 minute) processing times for the cells. The
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V values for substrate uptake in other species of max r r
trypanosomes are also lower than reported in this work.
Sanchez and Read, (1969) reported a Vmax equivalent to
0.05mM sec  ^ at 37°C in T. equiperdum and Southworth
and Read, (1969) reported a V of 0.33mM sec  ^ at 37°Cr max
in T. gambiense. The methods for measurement of uptake 
used were similar to those used by Gruenberg et al.,
(1978) .
The kinetic parameters for D-glucose metabolism at
20°C as measured in the oxygen electrode were Km = 0.387
t O.llmM and V = 20.3nmoles/min/10^ cells. Since max
Q
the cell volume is 1 .2ul per 10 cells, the V forr r max
D-glucose metabolism is 0.282mM sec Thus the K isb m
only slightly lower than the for D-glucose inhibition 
of 6-deoxy-D-glucose transport and the Vmax is only 
slightly lower than the Vmax for 6-deoxy-D-glucose 
transport. As the physiological concentration of D-glucose 
in the blood is approximately 5mM (Whitfield, 1979), 
transport will occur at close to maximum velocity as the 
concentration of D-glucose in the blood is well above 
the for D-glucose inhibition of 6-deoxy-D-glucose.
Thus, allowing for some backflux of D-glucose transport 
which may reduce the available D-glucose for metabolism, 
it seems likely that transport of sugars into T. brucei 
is rate-limiting for metabolism. This comparison is 
based on measurements made at 20°c but is also likely to 
apply at 37°C. The idea that transport is rate-limiting 
is supported by the fact that the metabolism of D-fructose 
is slower than D-mannose and D-glucose (Seed et al., 1965).
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Inhibition studies on 6-deoxy-D-glucose uptake have shown 
a higher value for D-fructose compared with the other 
sugar substrates (Table 7).
The rate-limiting nature of sugar uptake in T. brucei 
has important implications on the usefulness of the 
translocation step as a site for anti-trypanocidal agents. 
Despite transport being rate-limiting for metabolism, it 
is not a slow step and this is consistent with the high 
metabolic rate of trypanosomes compared with 
mammalian tissues. There are presumably a large number 
of D-glucose transporters and T. brucei may represent a 
rich source of this type of hexose transporter for more 
detailed study.
5.3: Specificity of hexose transport in T. brucei
The specificity of hexose transport was analysed 
using a series of inhibitors of 6-deoxy-D-glucose 
transport. The hydrogen bonding requirements were 
investigated using deoxy and deoxy-fluoro analogues of 
D-glucose. The fluorine atom is capable of forming a 
hydrogen bond with a neighbouring hydrogen atom but not 
a neighbouring oxygen atom. Where possible, spatial 
constraints on the hexose binding site were investigated 
using analogues with bulky groups substituted at the 
appropriate positions. Inhibition of 6-deoxy-D-glucose 
uptake was expressed by measurement of half-maximal 
inhibition constants (K/s) (See Table 7).
There are only four substrates of metabolism in
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T. brucei: D-glucose, D-mannose, D-fructose and glycerol.
Of these, glycerol did not significantly inhibit uptake 
of 6-deoxy-D-glucose. This indicates that the hexose 
transporter has no ability to transport glycerol.
Other workers have found that glycerol inhibits uptake of 
sugars into trypanosomes. Ruff and Reed, (1974) suggested 
the presence of a separate glycerol transporter but 
indicated that glycerol could also enter the cell via 
a sugar transport site in T. equiperdum. Similar 
findings were shown in T. b. gambiense(Southworth and Read, 
1969; 1970). The procedures for the measurement of 
uptake used by these workers were such that only 
phosphorylated metabolites would be retained within the 
cell after the long cell processing times used in the 
experiments. The inhibitory effect of glycerol is thus 
most likely to have been at the metabolic level. Under 
anaerobic conditions, high levels of glycerol are toxic 
to trypanosomes. Glycerol transported into the cells 
would rapidly deplete ATP levels via the action of 
glycerol kinase (Opperdoes and Borst, 1977). The loss 
of ATP would result in the reduction of other 
phosphorylated substrates and hence show an apparent 
inhibition of substrate uptake. The assay procedures used 
by previous workers would result in anaerobic conditions 
for at least part of the incubation period. For example, 
the inhibition experiments used 2ml of incubation medium
g
containing ImM substrate and at least 6 x 10 trypanosomes. 
Assuming metabolism of ImM D-glucose occurs at half the
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maximum rate calculated by Flynn and Bowman (1973), 
approximately 540nmoles of substrate are metabolised 
during the 2 minute incubation period. Since 1 mole 
of molecular oxygen is consumed per mole of D-glucose 
metabolised, this would result in the consumption of 
540nmoles of C^. Buffer saturated with air at 37°C 
contains oxygen at a concentration of 240pM (Robinson 
and Cooper, 1970) which, in 2ml of medium, is 
480nmoles of oxygen. Thus all oxygen would be used 
before the termination of incubation and anaerobic 
conditions would occur. The concentration of oxygen 
in the buffer is also likely to be significantly less 
than 240pM at the start of incubation because 1ml of 
medium containing the cells was preincubated to remove 
D-glucose from the intracellular and extracellular 
space prior to the addition of the cells to buffer 
containing the substrate and inhibitor.
Later work by Gruenberg et al., (1976) showed 
that glycerol inhibition of D-glucose uptake displayed 
different kinetics to glycerol inhibition of 2-deoxy-D- 
glucose. This is indicative of the problems of 
measuring transport rates using substrates which are 
metabolised. Gruenberg et al., (1976) concluded that 
glycerol inhibition was occurring at the metabolic 
level rather than at the carrier site and went on to 
propose a separate asymmetric glycerol permeation 
process (Gruenberg et al., 1980).
In the present study, the use of non-metabolised
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6-deoxy-D-glucose as a substrate for hexose transport 
has clearly shown that glycerol does not interact with 
the hexose transporter.
5.3.1: Specificity at carbon-1 (C-l)
The results obtained using the fluoro and the deoxy- 
fluoro analogues indicate that no hydrogen bond is 
directed towards the oxygen of the C-l hydroxyl group. 
However, the affinity of 1-deoxy-D-glucose is low 
compared with that of D-glucose which suggests that a 
hydrogen bond may be formed between the hydrogen of the 
C-l hydroxyl group and an electronegative group on the 
binding site. A close approach to the binding site is 
indicated at the C-l position due to the lack of 
inhibition by oc-methyl-D-glucoside and thus no space 
would appear to be available for the accomodation of 
bulky substituents. In the human erythrocyte, a 
hydrogen bond is directed to the C-l hydroxyl group but 
the close approach to the transporter is also indicated 
(Barnett et al., 1973a). Similar specificity 
requirements have also been shown for the rat adipocyte 
(Holman et al., 1981) and the intestinal basolateral 
membrane hexose transport system (Wright et al., 1980). 
The sodium-dependent active sugar cotransporter found 
in the brush border of intestine and kidney tubules 
(Crane, 1960) differs in its specificity with both 
cc- and 0 -methyl glucosides strongly inhibiting sugar 
uptake. The glycoside phloridzin, a potent inhibitor
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of active sugar cotransport (Alverado and Crane, 1962) 
can also be considered a C-l analogue with a phloretin 
moiety attached to the carbon-1 of D-glucose. This 
must reflect the spatial freedom around the C-l position 
in the sodium-dependent cotransport system. The 
inhibitory effect of phloridzin in the trypanosomal 
system where such spatial freedom is not evident may 
be due to the interaction of the phloretin component of 
the glycoside. Phloretin itself could not be tested as 
an inhibitor at the concentrations used with phloridzin 
due to its low aqueous solubility.
The trypanosomal transporter appears to accept 
both pyranose ring structures and certain open chain 
structures as 1-deoxy- and 1-fluoro-1-deoxy-D-glucose 
are fixed in the ring form. D-fructose can form an 
open chain structure resembling the pyranose ring 
conformation and is accepted quite well by the 
transporter. It may be that this open chain structure 
is responsible for the higher value and slower 
metabolism compared with D-glucose and D-mannose. In 
the mammalian transport systems D-fructose generally 
has a poor affinity for the hexose transporter. (Crane, 
1960; Wright et al., 1980).
5.3.2: Specificity at carbon-2 (C-2)
The inhibition results of the carbon-2 epimer. 
D-mannose, the deoxy and the deoxy-fluoro analogues 
indicate that no hydrogen bonding occurs at the C-2
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position. This is also the case for the erythrocyte 
and adipocyte transporters (Barnett et al. , 1973a;
Holman et al., 1981) but is markedly different from 
the intestinal sodium cotransport system (Crane, 1960) 
where an absolute requirement for the gluco-configuration 
at C-2 is shown. The trypanosomal transporter has only 
moderate affinity for D-glucosamine (K^ = 21.34mM) which 
may indicate poor acceptance of the protonated and 
charged amino group. This affinity is partially restored 
for N-acetyl-D-glucosamine (K^ = ll.llmM). It may be 
that considerable spatial freedom is available at the 
C-2 position in contrast to the mammalian transproters.
In the human erythrocyte transporter, 2-0-methyl-D- 
glucose has 20-fold less affinity for the transporter 
than D-glucose (Barnett et al., 1973a). The C-2 position 
may represent a site for selective binding of bulky 
substituents to the trypanosomal transporter.
5.3.3: Specificity at carbon-3 (C-3)
The inhibiton constants of 3-deoxy-D-glucose and
3-deoxy-3-fluoro-D-glucose (no inhibition and 2.31 t
0.34mM respectively) indicate a requirement for a 
hydrogen bond at the C-3 position as the fluoro atom 
restores the loss of affinity shown by the deoxy- 
analogue. However, the affinity of the fluoro- analogue 
is between 2 and 3-fold lower than that of D-glucose.
This could indicate additional hydrogen bonding to the 
hydrogen atom of the C-3 hydroxyl group. 3-0-methyl-D- 
glucose, which retains the oxygen of the hydroxyl group
166
has only moderate affinity for the transport site 
(K^ = 15.38mM). This is probably a consequence of 
spatial interference by the methyl group but may also 
be due to the absence of the hydrogen of the C-3 
hydroxyl group. 3-0-methyl-D-glucose is rapidly 
transported by erythrocytes and adipocytes and is 
generally described as non-metabolised (Whitese‘11 and 
Gliemann, 1979; Gliemann et al., 1972). We have 
indirect evidence that 3-0-methyl-D-glucose is 
phosphorylated by T. brucei. The results shown in 
Figure 20 indicate that 3-0-methyl-D-glucose behaves 
exactly as 2-deoxy-D-glucose, an analogue known to be 
phosphorylated, when uptake is measured following, or 
without a 3 minute preincubation period. Under the 
conditions used, only phosphorylated substrate was 
retained within the cells and this trapped radio-label 
was reduced to a leakage level when preincubation 
depleted ATP levels and no phosphorylation could occur.
5.3.4: Specificity at carbon-4 (C-4)
Deoxy- and deoxy-fluoro analogues were not available 
at the C-4 position. However, the total lack of 
inhibition or transport by D-galactose suggests that 
a gluco-conformation may be essential for interaction 
with the transporter. The lack'of inhibition by 
4,6-0-ethylidene-D-glucose was probably due to steric 
interference by the ethylidene group suggesting a close 
approach to the transporter at C-4. Considerable
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spatial freedom and limited hydrogen bonding is seen 
at the C-4 position in mammalian transport systems.
5.3.5: Specificity at carbon-5 (C-5)
The analogue 5-thio-D-glucose showed moderate 
inhibition (K^ = 11.67mM) which indicates that the ring 
oxygen is not an essential requirement for binding. 
However, a ring oxygen may be involved ,in a hydrogen 
bond since the 5-thio derivative has 10-fold lower 
affinity than D-glucose.
5.3.6: Specificity at carbon-6 (C-6)
The C-6 hydroxyl group is not required for hydrogen 
bonding since the for 6-deoxy-D-glucose has only 
1.5-fold less affinity than D-glucose. Some hydrophobic 
bonding is likely at this position since D-xylose, on 
which the C-6 hydroxy-methyl group is absent, shows no 
affinity for the transporter. Also, 6-chloro-6-deoxy- 
D-glucose has a lower affinity than D-glucose.
In the human erythrocyte, increasing the bulk of 
alkyl groups attached at C-6 resulted in increased 
affinity for the binding site (Barnett et al. , 1973a).
This was thought to be due to an interaction with a 
hydrophobic region adjacent to the C-6 position. A 
similar situation exists in the adipocyte where 
6-0-pentyl-D-galactose has higher affinity than D- 
galactose, but 6-0-methyl-D-galactose showed lower affinity
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than both D-galactose and the 6-0-pentyl derivative 
(Holman et al., 1981).
It is clear from these results that the specificity 
of the T. brucei hexose transporter differs in many 
respects from mammalian transport proteins. Models 
for the binding of D-glucose to the carrier have been 
proposed on the basis of specificity results and 
Figure 50 shows a model of the glucose-carrier complex 
for the human erythrocyte. A similar model has also 
been proposed for the rat adipocyte (Holman et al.,
1981). The model shows that carbon-4 and to some extent 
carbon-6 are outward-facing and thus able to accept 
bulky alkyl groups without loss of affinity for the 
binding site.
A possible model for the trypanosomal sugar-carrier 
complex is shown in Figure 51. A major difference 
between the mammalian and trypanosomal transport models 
is that the C-4 position does not appear to be outward- 
facing in the trypanosome. Evidence suggests a close 
approach of carbon-4 to the binding site but more 
information would be necessary to prove this conclusively. 
It is possible that the carbon-2 position is outward- 
facing in the trypanosomal binding site which would 
indicate a reversal of the sugar orientation in the site. 
Again more information is needed on the extent of the 
spatial freedom at the C-2 position which thus far 
represents the only site where the specificity 









Figure 50: Model of the D-glucose-carrier complex in
the human erythrocyte (from Barnett et al. , 
1973). Broken lines indicate hydrogen bonds.
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systems and therefore represents the only potential 
site for selective binding and possible transport of 
bulky substituents into the trypanosome. The proposed 
model (Figure 51) indicates a close approach to the 
binding site at the C-6 position. Evidence of lack of 
inhibition of C-6 analogues with bulky substitutions is 
also required to confirm the proposed model.
The inhibition experiments were carried out 
effectively under zero-trans conditions and thus measure 
inhibition of binding to the external site only. 
Side-specific analogues have been used in the adipocyte 
to demonstrate asymmetry in the inner and outer binding 
sites of the transport system which is not shown by the 
kinetics for a transported sugar in this system (Holman 
and Rees, 1982). Similar experiments would need to be 
carried out with trypanosomes to investigate whether 
the transporter is symmetrical with respect to both 
kinetics and specificity. Such data would be revealing 
in terms of the mechanism of the transport process in 
T. brucei.
5.4: The relationship between uptake and phosphorylation
When 1-deoxy-D-glucose was examined as a substrate 
for hexokinase from a crude trypanosomal extraction, 
the rate of 1-deoxy-D-glucose phosphorylation was less 
than 0.1% of the rate measured using D-glucose.
It was for this reason that 1-deoxy-D-glucose was 
considered as a non-metabolisable analogue. However
Sol u t ion
Figure 51: Model for the proposed structure of the
D-glucose-carrier complex in T. brucei. 
Broken lines represent probable hydrogen 
bonds.
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later studies using TLC analysis of transported 1-deoxy- 
D-glucose revealed that approximately 50% was in the 
phosphorylated form, indicating that in vivo 1-deoxy-D- 
glucose is a substrate for either hexokinase or 
another means of phosphorylation. It was at this stage 
that the presence of a group translocase system for 
sugar uptake was investigated. Such a system is 
attractive as it provides a means of regulation at the 
uptake stage and substrate is accumulated without 
expending metabolic energy (Postma and Roseman, 1976; 
Waygood et al., 1984).
The uptake experiments using 6-deoxy-D-glucose
indicated that phosphorylation of the substrate was not
necessary for transport to occur but this does not
preclude close coupling of the transport and
phosphorylation process. A linked transport and
phosphorylation step has been proposed for the yeast
D-glucose transport system (Van Steveninck and Rothstein,
1965; Jaspers and Van Steveninck, 1975; Tijssen et al.,
1984). The demonstration of a similar V for sugarmax °
transport and for D-glucose metabolism in this thesis 
could also be regarded as being consistent with a linked 
system.
Bisson and Fraenkel, (1983) showed that in kinase 
deficient mutants of Saccharomyces cerevisiae, high 
affinity uptake of 6-deoxy-D-glucose was lost. This 
indicates that the kinase is necessary for high affinity 
transport to occur, but not by direct phosphorylation 
of the substrate as 6-deoxy-D-glucose cannot be
173
phosphorylated at the C-6 position. It is possible that 
6-deoxy-D-glucose may still bind to the kinase during the 
transport process. The work with yeast shows that 
6-deoxy-D-glucose can be transported by a linked 
transport phosphorylation process. However, this would 
require hexokinase to be present in the cytosol or 
associated with the membrane whereas hexokinase is 
reported to be located almost entirely within the 
glycosome (Misset and Opperdoes, 1984).
Studies on the extent of phosphorylation of 1-deoxy- 
D-glucose after long (20  minutes) preincubation without 
metabolisable substrate, indicated that approximately 
507o of 1-deoxy-D-glucose was phosphorylated within a 3 
second uptake period (See Figure 2 3 ) .  As these 
preincubation times were sufficient to stop cellular 
motility it was assumed that ATP levels had been 
completely depleted. However some supply of phosphate 
energy (ATP or ADP + myokinase activity) must remain 
for phosphorylation of transported 1-deoxy-D-glucose.
One possibility is that ATP levels remain constant 
inside the glycosome and can be used to phosphorylate 
substrate once inside the organelle. There is no net 
change in ATP levels within the glycosome during 
glycolysis (Opperdoes, 1987). It is therefore possible 
that, if substrate levels are depleted, only the net 
ATP provided by the action of pyruvate kinase on 
phosphoenol pyruvate in the cytosol is depleted. As no 
substrate enters the glycosome, no ATP would be
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consumed until substrate is restored ie, 1-deoxy-D- 
glucose which is then phosphorylated until all 
available ATP is utilised. Alternatively, if ATP levels 
do become depleted in the glycosome, uptake of substrates 
may activate myokinase, also present within the 
glycosome, to synthesise ATP from ADP.
It still remains to be established whether carrier- 
mediated transport occurs in the glycosome. Since 
functional glycosomes have never been produced the 
metabolic processes that occur within the glycosome 
cannot be fully understood. Recently, it has been 
reported that any small neutral and charged molecule can 
freely diffuse into and out of the glycosome (Patthey and 
Deshusses, 1987).
If this were the case it is difficult to see how 
the presence of the glycosome could confer significant 
advantage to the trypanosome. In particular, the 
proposed synthesis of net ATP by reversal of glycerol 
kinase during anaerobic respiration could not occur as 
high levels of cc-glycerol phosphate are thought to be 
necessary for the reaction to proceed (Hammond and 
Bowman, 1980). It is possible that transport across 
the plasma membrane is not coupled to phosphorylation 
but transport across the glycosomal membrane is 
coupled to phosphorylation. However, it is most likely 
that phosphorylation of substrate within the glycosome 
relies on the high activity of hexokinase (Opperdoes and 
Borst, 1977).
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Microbial transport is usually by means of high- 
affinity active uptake systems as substrates are often 
present at very low concentrations. There are however 
some microbial facilitative diffusion transport systems, 
the sugar transport system of Zymomonas mobilis for 
example (Dimarco and Romano, 1985). In this case, 
substrate levels are high and the energy yield of 
metabolism (via the Entner-Doudoroff pathway) is only 
1 ATP molecule per molecule of D-glucose. This is a 
similar situation to the bloodstream form of T. brucei 
and is instructive in rationalising the evolution of 
a non energy-1 inked non-concentrative mode of uptake.
5.5: Future work
A) The specificity study could be extended to 
clarify the requirements at the C-6 and C-2 position.
This would establish whether the model for the substrate- 
carrier complex proposed in this discussion is correct. 
Specificity studies on the inside binding site could 
provide evidence for the mechanism of the transport 
process.
B) Should further specificity studies confirm 
the unique spatial freedom at the C-2 position of the 
trypanosomal transporter binding site, the specific 
uptake of 'metabolic poisons', or the binding of 
high-affinity or irreversable inhibitors could be 
investigated with the aim of producing an anti­
trypanosomal treatment. The potential effectiveness
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of such inhibitors is enhanced by the accessibility of 
the transporter protein to suitable agents. Also, as 
transport does appear to be rate-1imiting for metabolism, 
an inhibitor may slow the metabolism of trypanosomes 
sufficiently to affect the course of infection of the 
host.
C) The methodology described in this thesis allows 
the transport process to be studied in isolation from 
the metabolism that occurs within the cell. The 
transport site could therefore be investigated as a 
site of action for other trypanocidal agents. For 
example, preliminary studies on inhibition of uptake 
and efflux of 6-deoxy-D-glucose by trivalent arsenical 
compounds (results not shown) have indicated that the 
transport step may be an important site of action.
Such studies could also reveal the amino acids present 
in the active site of the transporter.
D) The transport protocols could be adapted to 
study uptake and efflux of substrates into the glycosome. 
To establish whether carrier-mediated transport occurs
in these organelles would significantly advance the 
understanding of the function of the glycosome.
5.6: Conclusions
Although the bloodstream form of T. brucei is 
only one stage of the life-cycle of one species of 
trypanosome, it is important in terms of the infection 
of mammals with African trypanosomiasis. Advances in
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the treatment of the victims of Sleeping Sickness are 
most likely to result from a greater understanding of 
the potential sites for chemotherapeutic attack. In 
this context, the work in this thesis has attempted 
to improve the understanding of the hexose transport 
process in T. brucei and begin to examine the 
suitability of this process as a site for the action of 
trypanocidal agents.
Although much more work is required, the results 
of this study have shown that, like many other aspects 
of the biochemistry and morphology of T. brucei, the 
transport process differs in some respects from 
mammalian systems. The transport process may thus be 
suitable for the action of a selective trypanocidal 
agent, based on the differing specificities of the 
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Sugar transport in Trypanosoma brucei: a suitable kinetic 
probe
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A transport assay has been developed for use in the investigation of 1-deoxy-D-glucose uptake in trypano- 
somes. 1-Deoxy-D-glucose has high affinity for the trypanosome sugar transport system (net influx ATm=4.03 
+ 0.42 mM; V=  0.052 + 0.005 mM • s 1. D-Glucose oxidation is competitively inhibited by 1-deoxy-D- 
glucose. However, we show that 1-deoxy-D-glucose is not a substrate for metabolism and that the competi­
tion occurs because of interaction at the transport system. D-Glucose competitively inhibits 1-deoxy-D-
glucose influx.
(Trypanosoma brucei) Sugar transport D-Glucose 1,5-Anhydro-D-glucitol 1-Deoxy-D-glucose
1. INTRODUCTION
The long slender bloodstream form of African 
trypanosomes of the brucei group is totally depen­
dent on glycolysis for ATP production, and con­
sumes D-glucose at rates which are up to 10-times 
those of the most glycolytically active mammalian 
cells (review [11). This high flux is favoured by the 
localisation of most of the glycolytic enzymes in 
the glycosome [2] and the possible further com- 
partmentation of these enzymes in a multi-enzyme 
complex [3]. Glycolytic flux in brucei trypano­
somes appears to be uncontrolled in the sense that 
little evidence has emerged for modulation at the 
enzyme level. Studies of the classical glycolytic 
pacemakers, hexokinase [4,51, pyruvate kinase [6] 
and phosphofructokinase [4,7] have shown that 
these enzymes are unlikely to play a regulatory role 
through interactions with metabolic intermediates 
acting as positive or negative effectors.
Although much work has been published on the
Dedicated to S.P. Datta upon his retirement as Manag­
ing Editor of FEBS Letters
* To whom correspondence should be addressed
nature and function of glycolysis in these 
organisms, the initial step, i.e. the transport of D- 
glucose across the plasma membrane, has received 
relatively little attention. Early studies of sugar 
transport in Trypanosoma gambiense [8,9] were 
interpreted as providing evidence for separate 
transporters for D-fructose and for D-glucose. 
More recently, Gruenberg et al. [10] have reported 
kinetic studies of D-glucose and 2-deoxy-D-glucose 
transport in T. brucei and concluded that a D- 
glucose transporter exists in this organism and that 
the uptake process is the rate-limiting step of D- 
glucose metabolism. However, as pointed out by 
Visser et al. [11] the high glycolytic flux poses a 
problem in the interpretation of uptake ex­
periments involving metabolised sugars since most 
of the results published represent steady-state 
rather than initial rate measurements. It is clear 
that meaningful transport kinetics can only be ob­
tained with intact cells by using D-glucose 
analogues which are non-metabolised and not 
phosphorylated. Such analogues would allow the 
dissection of effects of potential trypanocidal 
agents on transport from those on metabolism. We 
have found that 3-O-methylrD-glucose, the 
analogue most often used for such studies in mam-
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malian cells, is a very poor substrate for the 
trypanosome transporter and we have looked for a 
suitable alternative. We now report kinetics of up­
take of 1,5-anhydro-D-glucitol and we show that 
this analogue is a good non-metabolised substrate 
for the trypanosome transporter.
2. EXPERIMENTAL
2.1. Materials
Enzymes and co factors were purchased from 
Sigma. 1,5-Anhydro-D-glucitol (1-deoxy-D-glu­
cose) was synthesised as described by Barnett et al. 
[12]. Radiolabelled 1-deoxy-D-glucose was 
prepared similarly except that D-[U-14C]glucose 
(275 mCi/mmol) was used. All other reagents were 
of analytical grade.
Cells of the long slender form of T. brucei were 
isolated from Wistar or Sprague-Dawley rats 
(250-400 g) infected with 1-3 x  107 cells of strain 
MITat 1.1 as described [13], and purified on a 
DEAE-cellulose column [14], After preparation 
the cells were kept at 0°C in storage buffer (98 mM 
NaCl, 22 mM KH2PO4, 1 mM MgSC>4, 2 mM 
KC1; pH 8.0) containing 10 mM D-glucose.
2.2. Transport measurements
Immediately before the uptake experiment D- 
glucose was removed by centrifuging a cell suspen­
sion, suspending the pellet in cold storage buffer, 
recentrifuging and resuspending the pellet in an ap­
propriate volume of buffer for the transport ex­
periment. All centrifugations were carried out in 
an Ole-Dich refrigerated microfuge (15000 x g, 
20 s, 0°C) to ensure rapid processing of the cells.
The cells were preincubated at 37 °C for 30 s and 
then 0.1-0.3/fC i l-deoxy-D-[U-14C]glucose, di­
luted with an appropriate concentration of 
unlabelled sugar was added. At appropriate inter­
vals duplicate 200-^1 samples were removed, using 
a multi-channel pipette, and dispersed into vials 
containing 1 ml ice-cold storage buffer. The vials 
were immediately centrifuged and the supernatants 
removed. The pellets were resuspended and the 
wash stage was repeated; the supernatants were 
carefully removed. Carry-over of radiolabel or 
zero time uptake was estimated from samples 
which were added directly to ice-cold buffer. The 
cell pellets were lysed in distilled water and dis­
persed into scintillant for liquid scintillation coun­
ting. For the estimation of Km generally just a 
single time point was used (30 s). In addition, for 
the lowest substrate concentration used, samples 
were taken after cellular equilibration with 
substrate had been reached (2-3 min). This pro­
vided an estimate of the volume of the cells accessi­
ble to the substrate so that rates could be 
calculated in units of concentration-time-1. For 
the D-glucose inhibition experiment, cells were 
suspended in buffer containing the appropriate 
concentration of D-glucose before the addition of 
1-deoxy-D-glucose. Kinetic constants were 
calculated using the direct linear plot [15] or by 
least squares.
2.3. Hexokinase assay
Hexokinase activity was determined by measur­
ing the production of ADP in a coupled system 
containing pyruvate kinase and lactate de­
hydrogenase at 25°C. The assay buffer (pH 7.4) 
contained 0.4 M triethanolamine, 2 mM EDTA, 
4 mM MgCl2, 4 mM KC1, 0.5 mM ATP, 0.5 mM 
phosphoewo/pyruvate, 0.5 mM NADH, 5 units 
pyruvate kinase, 5 units lactate dehydrogenase. 
Hexokinase was assayed in a sonicated cell lysate 
or a disrupted glycosomal preparation prepared 
essentially as described by Oduro et al. [16]. A cor­
rection was made for NADH oxidase activity. 
NADH oxidase activity was determined by omis­
sion of ATP and phosphoewo/pyruvate and was 
found to be less than 0.5% of maximal hexokinase 
activity. Trypanosome respiration rates were 
estimated at 37°C using a Clark oxygen electrode.
3. RESULTS AND DISCUSSION
1-Deoxy-D-glucose (10 mM) showed no de­
tectable ADP production in an assay for hexo­
kinase activity (<0.1% of the rate with D-glucose 
under assay conditions) in either sonicated cell 
lysates or in a disrupted glycosome preparation. 
1-Deoxy-D-glucose, at concentrations ’ up to 
10 mM, did not inhibit hexokinase activity, even at 
the lowest D-glucose concentration tested 
(0.25 mM).
Oxidation of D-glucose in trypanosomes is 
however inhibited by 1-deoxy-D-glucose. The in­
hibition was substrate-antagonised as shown in 
fig .l. Here the fractional inhibition at fixed in­
hibitor concentration decreases with increasing D-
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P E R C E N T A G E
INHIBITION
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Fig.l. Inhibition of rate of D-glucose respiration in T. 
brucei by 40 mM 1-deoxy-D-glucose. Percentage 
inhibition is given by 100 x (1 -  (Vi/v0)) where Vi and v0 
are the rates of oxygen utilisation in the presence and 
absence, respectively, of 1-deoxy-D-glucose.
glucose concentration. Because of the lack o f in­
teraction of D-glucose and 1-deoxy-D-glucose at 
the hexokinase level the observed effect of
1-deoxy-D-glucose on respiration is likely to be 
mediated at the membrane transporter.
In order to set up procedures for investigating 
sugar interactions with their transport system a 
number of agents were tested as stoppers in uptake 
experiments. At 37 °C neither /?-hydroxy- 
mercuribenzoate, nor mercuric chloride, nor 
cytochalasin B was totally effective. However, a 
5-fold dilution with ice-cold buffer was sufficient 
to prevent efflux of label. In the experiment shown 
in fig.2 cells were equilibrated with 50 /*M 1-deoxy- 
D-glucose and then diluted into ice-cold buffer. No 
efflux was observed over a time course which was 
much longer than the cell processing time required 
for estimating trapped label (see section 2).
The time course for 50 1-deoxy-D-glucose 
uptake is shown in fig.3. From the equilibrium 
level of substrate it is calculated that the available 
cell volume is 5.9 ^ l/lO 8 cells. This value is midway 
between those reported by other workers [17,18]. 
The approach to equilibrium shown is typical for
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Fig.2. Efflux of 1-deoxy-D-glucose from T. brucei 
(equilibrated with 50 /M. 1-deoxy-D-glucose) by dilution 
with 5 vols buffer at 0°C (•) and 37°C ( a ). For details 
see text.
the flux of a substrate concentration below the K m. 
The data fitted the integrated rate equation [19] 
from which an initial rate was calculated (fig.3, in­
set). This showed that a 30 s time point gave an ac­
curate estimate of the initial rate. In experiments in 
which K m estimates for 1-deoxy-D-glucose were 
made a 30 s time point was generally used. A 45 s 
time point gave similar results. Variation of initial 
rates with 1-deoxy-D-glucose concentrations 
followed Michaelis-Menten kinetics. From the 
direct linear plot shown in fig.4 K m = 4.03 ± 
0.42 mM and V  = 0.052 ± 0.005 m M -s '1 were 
calculated. The clustering of the intersections of 
this plot gives a visual estimate of the error in the 
kinetic parameters. Uptake rates were competitive­
ly inhibited in the presence o f added D-glucose 
(fig.4, inset). In these experiments the conditions 
were adjusted to ensure that the D-glucose concen­
tration outside the cells did not change by more 
than 10% during the incubation. The estimated Ky 
is 0.33 ± 0.05 mM but since the D-glucose concen­
tration inside the cells is unknoyvn the extent to 
which this value represents a true transport inhibi­
tion constant is unclear. However, this operational
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Fig.3. Time course of 1-deoxy-D-glucose uptake (50/iM) by T. brucei at 37°C. Inset: data fitted to integrated rate
equation [19].
K[ is 10-fold lower than the half-maximal satura­
tion constant for D-glucose oxidation and 3-fold 
lower than the K\ for D-glucose inhibition of
2-deoxy-D-glucose uptake and than the K m for D- 
glucose uptake [10].
Further investigations o f the specificity o f this 
transport system are required. However, it is clear 
that this system is dissimilar to both bacterial and 
mammalian transport systems for sugars. E. coli 
GalP and MG phosphotransferase systems do not 
transport 1-deoxy-D-glucose [20] (P .J.F . Hender­
son, personal communication). Mammalian sugar 
transport systems will transport 1-deoxy-D-glucose 
but removal o f the hydroxyl at carbon 1 results in 
a large affinity loss. The K m in mammalian systems 
is 80-90 mM [12,21] which is a considerably lower 
affinity than that which we now report for the 
trypanosome system. Another marked difference 
between the trypanosom e and mammalian systems 
is the difference in affinity for 3-O-methyl-D-
glucose. In the mammalian system the addition of 
the methyl group at C-3 has no effect on affinity 
but in trypanosomes a huge loss o f affinity occurs. 
The rates o f 3-O-methyl-D-glucose uptake in 
trypanosomes are less than 10% of the rates o f 
1-deoxy-D-glucose uptake. However, 6-deoxy-D- 
glucose (quinovose) was found to be an effective 
inhibitor o f 1-deoxy-D-glucose uptake, and this 
analogue may also be suitable for studies of sugar 
transport in these cells.
The influx V  for trypanosome sugar transport is 
slower than that for mammalian systems. In view 
of the much higher glycolytic rate in trypanosomes 
it seems likely that in these organisms overall D- 
glucose oxidation rates are more rate limited by 
membrane transport than in mammalian cells.
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Fig.4. Direct linear plot of variation of uptake rate with initial 1-deoxy-D-glucose concentration. Inset: double­
reciprocal plots of uptake rates at different fixed D-glucose concentrations: no glucose (•), 0.5 mM (■), 1 mM ( A) .
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deposition. Our failure to demonstrate any reduction in the 
amount of mixed muscle protein does not preclude the 
possibility that chronic ethanol ingestion in rats may reduce 
the amount of specific myofibrillar proteins as suggested in 
alcoholic patients (Martin et al., 1984).
In conclusion, the chronically treated ethanol-fed rat is a 
suitable model to study skeletal muscle myopathy. Anatom­
ically distinct muscles provide a useful basis to examine 
types I and II fibres and demonstrate contrasting responses 
to treatment.
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Sugar transport in Trypanosoma brucei
KEVIN CONROY, ROBERT EISENTHAL,
STEPHEN GAME and GEOFFREY HOLMAN 
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The bloodstream form of Trypanosoma brucei is dependent 
on glucose metabolism for energy production. Glycolysis is 
thought to be localized mainly if not totally in the glycosome 
(Opperdoes & Borst, 1977) and much has been reported on 
the functional features of this organelle (Opperdoes, 1985). 
Much less attention has been directed at the initial step of 
glucose metabolism, i.e. the transport of sugar across the 
plasma membrane. The results of Gruenberg et al. (1978) 
indicated that glucose transport is likely to be the rate- 
limiting step in glucose metabolism, but those studies 
involved the use of 2-deoxyglucose which is known to be a 
substrate for hexokinase. Recently Game et al. (1986) 
reported that 1-deoxy-D-glucose may be a suitable analogue 
for studying sugar transport in T. brucei. Their results 
on 1-deoxy-D-glucose influx demonstrated that the V  for 
trypanosome sugar transport is slower than that for 
mammalian systems. However, attempts to characterize 
efflux and exchange kinetics of 1-deoxy-D-glucose effect 
were frustrated by a slow but significant phosphorylation of 
the analogue.
Game et al. (1986) also reported that 6-deoxy-D-glucose 
was an effective inhibitor of 1-deoxy-D-glucose uptake. As 
this analogue is unlikely to undergo any metabolism, we 
have investigated the kinetics of its uptake and efflux in 
intact cells and have also studied D-glucose transport in 
vesicles prepared from trypanosome plasma membranes.
6-Deoxy-D-glucose was synthesized from 6-chloro-a- 
methyl-D-glucoside (Evans & Parrish, 1972) which was 
converted to the 6-iodo compound and then catalytically 
reduced with tritium gas (Amersham). This tritiated product 
was hydrolysed to remove the glycosidic methyl group and 
the resultant [6-3H]deoxy-D-glucose was then purified by 
paper chromatography.
Kinetic parameters for 6-deoxy-D-glucose were deter­
mined at 20°C. Net influx and efflux showed similar Km and 
values (Table 1) indicating the transport system is 
kinetically symmetric. An equilibrium exchange experiment 
in which isotope exchange flux was studied in cells pre­
equilibrated with non-labelled 6-deoxy-D-glucose also 
showed comparable kinetic parameters (Table 1). Thus the 
system does not show accelerated exchange. An integrated 
rate equation was used to determine the infinite-cw Km. This 
experiment confirmed kinetic symmetry for the transport of 
6-deoxy-D-glucose.
We have also studied hexose transport in purified plasma 
membranes. Vesicles were prepared by a freeze-thaw 
procedure. The freeze-thaw protocol was found to be essen­
tial to remove cytoskeletal components associated with the 
plasma membrane sheets. We have found that an infinite- 
trans protocol is most useful for studying the kinetics of 
transport in this isolated membrane system. In this 
procedure vesicles are loaded with lOOmM-D-glucose and 
then diluted into a buffer containing radiolabelled D-glucose 
at a range of concentrations. The high concentration of 
D-glucose inside traps (by counterflow) the radiolabelled 
D-glucose as it enters the vesicles. The estimated Km is shown 
in Table 1. The Km of 14mM is considerably higher than the 
affinity constant estimated by using intact cells and further 
experiments will investigate the reasons for the difference.
We are pleased to acknowledge financial support by the Wellcome 
Trust.
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Infinite-frans entry in vesicles
2.17 +0.068  
6.063 +  1.227 
6.212 +  1.197 
3.0 ±  0.332 
14.33 +  2.55
0.279 ±0.006  
0.863 ±  0.109 
0.601 ±  0.052 
0.965 +  0.067
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Proteolytic degradation of mucus in the colon
DAVID A. HUTTON, ADRIAN ALLEN,
WILLIAM J. CUNLIFFE and 
JEFFREY P. PEARSON
Department o f Physiological Sciences, Medical 
School University, Framlington Place,
Newcastle Upon Tyne NE2 4HH, U.K.
A continuous adherent layer of insoluble mucus gel is found 
on the colonic mucosal surface, mean thickness 150 + 
110/mi in the rat (Sakata & Engelhardt, 1981). Such a 
mucuos layer will provide a protective barrier against harm­
ful agents in the lumen and mechanical damage from motile 
forces of digestion. The protective gel layer is formed by 
polymeric glycoproteins which are fragmented by proteases 
to dissolve the mucous layer (mucolysis) (Allen et al., 1984; 
Bell et al., 1985). Recent studies of proteolytic activity in 
stools (using non-mucous protein substrates) showed that 
inflammatory bowel disease patients had significantly 
higher levels of activity compared to non-symptomatic 
controls (Corfield et al., 1986). If such proteolytic activity 
reflects excessive mucolytic activity (mucous degrading) 
then this may be an important factor in disruption of the 
colonic mucosal barrier in inflammatory bowel disease. 
Here we demonstrate mucolytic activity in human faecal 
extracts from non-inflammatory bowel disease patients.
Glycoproteins from pig and human colonic mucous and 
pig gastric mucuous were extracted in proteinase inhibitors 
[l.OmM-phenylmethylsulphonyl fluoride (PMSF), 50mM- 
iodoacetamide, 100mM-a-aminohexanoic acid, 5mM-benz- 
amidine HC1, 1.0 mg l -1 soybean trypsin inhibitor and 
10 mM-Na2 EDTA in 0.5 M-Tris/HCl pH 8.0] and purified by 
two successive equilibrium centrifugation steps in 3.5 m - 
CaCl2. Purified glycoproteins were largely excluded (>  60%) 
from Seph arose CL-2B and were fragmented into smaller 
species, included on Sepharose CL-2B, by reduction (0.2 m - 
mercaptoethanol 48 h, 4°C) and exhaustive proteolysis 
[1:100 (w/w) papain: glycoprotein, 48 h, 60°C]. This frag­
mentation was reflected by a substantial drop in solution 
viscosity (approximately 10-fold on papain digestion of pig 
colonic mucous glycoprotein at 4 mg ml-1).
Human faecal extracts (from non-inflammatory bowel 
disease patients) were obtained by suspending samples of 
stool in 4 vol. of m/1 5 m  phosphate buffer pH 7.5, containing 
50 mM-NaCl and centrifuging at 10 000 # for 15 min at 4°C. 
Protease activity was measured by a sensitive trinitro­
benzene sulphonic acid assay for formation of new peptide 
V-terminals at pH 7.5 and 37°C using succinyl albumin or 
purified mucous glycoprotein as substrate (Hutton et al., 
1986). Protolytic action on succinyl albumin by the extracts 
was inhibited by soybean trypsin inhibitor and PMSF 
(ImM) [but not by iodoacetamide (50 mM) or Na2 EDTA 
(10 mM)] suggesting that the activity was due to a trypsin­
like serine-dependent protease. Subsequently, levels of 
faecal protease activity (against succinyl albumin) were 
quantified as equivalents of porcine pancreatic trypsin
Abbreviation used: PM SF, phenylmethyl sulphonyl fluoride.
(Sigma) activity by weight. On this basis, faecal protease 
activity was completely inhibited by soybean trypsin 
inhibitor [1:1 (w/w) inhibitor: faecal protease activity] and 
the synthetic polyacrylate Carbomer 934P [1000:1 (w/w) 
polyacrylate: faecal protease activity]. PMSF [100:1 (w/w)] 
inhibited activity by ~60% . Mucolytic activity of the 
faecal extracts was assayed by monitoring the fall in 
specific viscosity of solutions of purified mucous glyco­
proteins, as a function of time, on incubation with faecal 
extract at pH 7.5 and 37°C. Mucolysis was also followed by 
measuring the increase in free Y-terminals and the amount 
of glycoprotein included in Sepharose CL-2B. In this 
manner, extracts were shown to proteolytically digest puri­
fied pig gastric and colonic mucous glycoproteins. For 
example, incubation of purified pig colonic muous glyco­
protein with extract [0.1 % enzyme: glycoprotein (w/w)] 
induced a rapid fall in the specific viscosity of the glyco­
protein in the first 15 min of digestion (74.5% of the fall in 
specific viscosity after complete digestion) followed by a 
slower fall over the subsequent 48 h. This fall in viscosity 
was accompanied by an increase in the proportion of glyco­
protein included on Sepharose CL-2B this being 35% at 
time 0, and 77% and 89% after 15 min and 24h, respective­
ly. Decrease in viscosity was also mirrored by an increase in 
the number of free iV-terminals and a 50% drop in specific 
viscosity corresponded to 3.1 x 10“5 mol of peptide bonds 
cleaved. The synthetic polyacrylate Carbomer 934P [1200:1 
(w/w) polyacrylate: faecal protease activity] inhibited 
mucolysis by 45%.
The polyacrylate Carbomer 934P, in addition to inhibit­
ing degradation of mucus, was shown to have a potential 
role in strengthening the protective mucous barrier. 
Carbomer 934P synergistically increased the viscosity of 
purified undegraded colonic mucous glycoproteins from 
both man and pig. Thus, viscosity of glycoprotein/carbomer 
mixtures (GC) was substantially greater than the sum of the 
individual viscosities (G +C ). This synergistic increase in 
viscosity was approximately 460% at concentrations of 
glycoprotein and carbomer of 4 mg m l-1 and 2 mg ml-1, 
respectively.
These studies demonstrate endogenous mucolytic activity, 
by proteases, exists in the lumen of the colon in vivo. Such 
mucolysis may be an important factor in disruption of the 
colonic mucous barrier in disease.
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